What changed in this filing

/stocks — the workspaceLOADING

Item 2. Management’s Discussion and Analysis

2021-05-10 compared with 2020-11-13 · 439 added, 581 removed, 622 unchanged (62% of the section changed)

14 unchanged sentences

Maiden Holdings is a Bermuda-based holding company, previously focused on serving the needs of regional and specialty insurers in the United States ("U.S."), Europe and select other global markets.

We are running off the liabilities associated with AmTrust Financial Services, Inc.

("AmTrust") contracts terminated in early 2019 as discussed below.

We are not actively underwriting reinsurance business.

We have also entered into a retroactive reinsurance agreement and a commutation agreement that further reduces our exposure to and limits the potential volatility related to these AmTrust liabilities, which are discussed in " Note 1.

Basis of Presentation " of the Notes to Condensed Consolidated Financial Statements included in Part I Item 1.

" Financial Information ".

We operate internationally providing branded auto and credit life insurance products through insurer partners to retail clients in the EU and other global markets through our wholly owned subsidiary Maiden Global Holdings, Ltd.

("Maiden Global").

These products also produce reinsurance programs which are underwritten by our indirect wholly owned subsidiary Maiden Reinsurance Ltd.

As a result of a series of actions we have taken in recent years discussed below under Recent Developments , we create shareholder value by actively managing and allocating our assets and capital, including through ownership and management of businesses and assets mostly in the insurance and related financial services industries where we can leverage our deep knowledge of those markets.

We also provide a full range of legacy services to small insurance companies, particularly those in run-off or with blocks of reserves that are no longer core, working with clients to develop and implement finality solutions including acquiring entire companies.

We expect our legacy solutions business to contribute to our active asset and capital management strategies.

Short-term income protection business is written on a primary basis by our wholly owned subsidiaries Maiden Life Försäkrings AB ("Maiden LF") and Maiden General Försäkrings AB ("Maiden GF") in the Scandinavian and Northern European markets.

Insurance support services are provided to Maiden LF and Maiden GF through our wholly owned subsidiary, Maiden Global Holdings, Ltd.

("Maiden Global") which is also a licensed intermediary in the United Kingdom.

Maiden Global had previously operated internationally by providing branded auto and credit life insurance products through insurer partners, particularly those in Europe and other global markets.

These products also produced reinsurance programs which were underwritten by our wholly owned subsidiary Maiden Reinsurance Ltd.

("Maiden Reinsurance").

Certain international credit life business is written on a primary basis by our wholly owned subsidiary Maiden Life Försäkrings AB ("Maiden LF") and general insurance business is written on a primary basis by our wholly owned subsidiary Maiden General Försäkrings AB ("Maiden GF").

As discussed in " Note 1.

Basis of Presentation " of the Notes to Condensed Consolidated Financial Statements included in Part I Item 1.

" Financial Information " and in Item 1.

We are not actively underwriting reinsurance business presently but have some historic reinsurance programs underwritten by Maiden Reinsurance which are in run-off.

We continue to run-off the underwriting liabilities related to our contracts with AmTrust Financial Services, Inc.

("AmTrust") which we terminated in 2019.

We also have a Loss Portfolio Transfer and Adverse Development Cover Agreement ("LPT/ADC Agreement") with Cavello Bay Reinsurance Limited ("Cavello") and a commutation agreement that further reduces our exposure to and limits the potential volatility related to these AmTrust liabilities, as discussed in " Note 8.

Reinsurance " of the Notes to Condensed Consolidated Financial Statements included in Part I Item 1.

"Financial Information" .

As discussed in Item 1.

" Business " of our Annual Report on Form 10-K for the year ended December 31, 2020 filed with the SEC on March 15, 2021, the sale of Maiden Reinsurance North America, Inc.

("Maiden US") and the termination of both of our quota share contracts with AmTrust have materially reduced our gross and net premiums written since 2018.

("Maiden US") and the termination of both of our quota share contracts with AmTrust materially reduced our gross and net premiums written since 2018.

We have significantly reduced our operating expenses and continue to take steps to reduce these costs further.

Our business consists of two reportable segments:

Our business currently consists of two reportable segments:

Diversified Reinsurance and AmTrust Reinsurance.

As a result of the strategic decision to divest all our U.S.

treaty reinsurance operations in 2018, we revised the composition of our reportable segments in the fourth quarter of 2018.

Our Diversified Reinsurance segment now only consists of a portfolio of predominantly property and casualty reinsurance business focusing on regional and specialty property and casualty insurance companies located primarily in Europe.

Our AmTrust Reinsurance segment includes the run-off of all business ceded by AmTrust to Maiden Reinsurance, primarily the AmTrust Quota Share and the European Hospital Liability Quota Share.

Our Diversified Reinsurance segment consists of a portfolio of predominantly property and casualty reinsurance business focusing on regional and specialty property and casualty insurance companies located primarily in Europe.

Our AmTrust Reinsurance segment includes all business ceded to Maiden Reinsurance by AmTrust, primarily the quota share reinsurance agreement (“AmTrust Quota Share”) between Maiden Reinsurance and AmTrust’s wholly owned subsidiary, AmTrust International Insurance, Ltd.

(“AII”) and the European hospital liability quota share reinsurance contract ("European Hospital Liability Quota Share") with AmTrust’s wholly owned subsidiaries AmTrust Europe Limited ("AEL") and AmTrust International Underwriters DAC ("AIU DAC"), which are both in run-off effective January 1, 2019.

Recent Developments

Since the third quarter of 2018, we have engaged in a series of transactions that have dramatically reduced the regulatory capital required to operate our business, materially strengthened our solvency ratios, and ceased active reinsurance underwriting.

Since the third quarter of 2018, we have engaged in a series of transactions that dramatically reduced the regulatory capital required to operate our business, materially strengthened our solvency ratios, and ceased active reinsurance underwriting.

During that time, we significantly increased our estimate of ultimate losses and loss reserves while purchasing reinsurance protection against further loss reserve volatility and as a result, have improved the ultimate economic value of the Company.

The measures we have taken were initiated in early 2018, when our Board of Directors initiated a review of strategic alternatives ("Strategic Review") to evaluate ways to increase shareholder value after a period of continuing higher than targeted combined ratios and lower returns on equity than expected.

The measures we have taken were initiated in 2018, when our Board of Directors initiated a review of strategic alternatives ("Strategic Review") to evaluate ways to increase shareholder value after a period of continuing higher than targeted combined ratios and lower returns on equity than expected.

This Strategic Review resulted in a series of transactions that transformed our operations and materially reduced the risk on our balance sheet.

These transactions can be found in Part II of our Annual Report on Form 10-K for the year ended December 31, 2019.

These transactions can be found in Part II of our Annual Report on Form 10-K for the year ended December 31, 2020 that was filed with the SEC on March 15, 2021.

Please refer to " Management's Discussion and Analysis of Financial Condition and Results of Operations " section included under Item 7 of our Annual Report on Form 10-K for the year ended December 31, 2020 for further information.

Effective March 16, 2020, we re-domesticated our principal operating subsidiary, Maiden Reinsurance, to the State of Vermont in the U.S.

Effective March 16, 2020, we re-domesticated our principal operating subsidiary, Maiden Reinsurance, from Bermuda to the State of Vermont in the U.S., having determined that re-domesticating Maiden Reinsurance to Vermont enables us to better align our capital and resources with our liabilities, which originate mostly in the United States, resulting in a more efficient structure.

Maiden Reinsurance is now subject to the statutes and regulations of Vermont in the ordinary course of business.

We have determined that re-domesticating Maiden Reinsurance to Vermont enables us to better align our capital and resources with our liabilities, which originate mostly in the United States, resulting in a more efficient structure.

The re-domestication, in combination with the transactions completed pursuant to the Strategic Review, will continue to strengthen the Company’s capital position and solvency ratios.

While the Vermont Department of Financial Regulation ("Vermont DFR") will be the group supervisor for the Company, the re-domestication did not apply to the parent holding company which remains a Bermuda-based holding company.

The re-domestication, in combination with other strategic measures described above that were completed in 2019, will continue to strengthen the Company’s capital position and solvency ratios.

While the Vermont Department of Financial Regulation ("Vermont DFR") is currently the group supervisor for the Company, the re-domestication did not apply to the parent holding company which remains a Bermuda-based holding company.

Securities issued by Maiden Holdings were not affected by the re-domestication of Maiden Reinsurance to Vermont.

2 unchanged sentences

Maiden NA now owns 100% of Maiden Reinsurance in the aggregate.

Maiden NA also maintains a portfolio of cash and fixed maturity investments, along with other strategic investments of $41.1 million at September 30, 2020.

We believe Maiden NA’s investments, including its ownership of Maiden Reinsurance, will create opportunities to utilize net operating loss carry-forwards ("NOLs") which total $211.6 million as of September 30, 2020.

These NOLs are not presently recognized as deferred tax assets as a full valuation allowance is currently carried against them.

Maiden NA also maintains a portfolio of cash and fixed maturity investments, along with other strategic investments, of $34.2 million at March 31, 2021.

We believe Maiden NA’s investments, including its ownership of Maiden Reinsurance and its active asset management strategy, will create opportunities to utilize net operating loss carry-forwards ("NOLs") which were $212.5 million as of March 31, 2021.

These NOLs, in combination with additional net deferred tax assets ("DTAs") of

primarily related to our insurance liabilities, result in a net DTA (before valuation allowance) of $88.1 million or $1.02 per common share as of March 31, 2021.

These net DTAs are not presently recognized on the Company's consolidated balance sheet as a full valuation allowance is currently carried against them.

For further details, please see "Note 16.

Taxation" included under Item 8 "Financial Statements and Supplementary Data" in our Annual Report on Form 10-K for the year ended December 31, 2019 filed with the SEC on March 18, 2020.

Taken together, the Company believes these measures should generate additional income for Maiden NA in a tax-efficient manner while sharing in the improvement in profitability anticipated in Maiden Reinsurance as a result of the measures enacted as part of the Strategic Review.

We expect to continue to re–evaluate our operating strategy during 2020 while leveraging the significant assets and capital we retain.

In addition to restoring operating profitability, our strategic focus will center on creating the greatest risk-adjusted shareholder returns, whether via asset and capital management or active reinsurance underwriting, or a combination of both.

Our present assessment of the reinsurance marketplace along with our current operating profile is that the risk-adjusted returns

that may be produced via active reinsurance underwriting are likely to present more limited opportunities compared to other strategic initiatives which may produce greater shareholder value.

Taxation" included under Item 8 "Financial Statements and Supplementary Data" in our Annual Report on Form 10-K for the year ended December 31, 2020.

Taken together, we believe these measures should generate additional income for Maiden NA in a tax-efficient manner, while sharing in the improvement in profitability anticipated in Maiden Reinsurance as a result of the measures enacted as part of the Strategic Review.

Business Strategy

We continue to re–evaluate our operating strategy during 2021 while leveraging the significant assets and capital we retain.

In addition to restoring operating profitability, our strategic focus centers on creating the greatest risk-adjusted shareholder returns, whether via asset and capital management or active reinsurance underwriting, or a combination of both.

Our present assessment of the reinsurance marketplace along with our current operating profile is that the risk-adjusted returns that may be produced via active reinsurance underwriting of new risks are likely to present more limited opportunities compared to other strategic initiatives which may produce greater shareholder value.

As a result, our strategic focus has shifted to activities which utilize our unrestricted cash and investments to manage our capital and where prudent, enhance our investment return by investing in asset classes which we believe will produce appropriate returns.

The measures implemented now enable the Company to more flexibly allocate capital to those activities most likely to produce the greatest returns for shareholders, and the Company is actively engaged in evaluating and deploying funds in both pillars of these strategies as discussed herein.

By enhancing our profitability through increased investment returns, we believe we also increase the likelihood of fully utilizing the significant NOLs described above which may create additional shareholder value.

The measures implemented now enable us to more flexibly allocate capital to those activities most likely to produce the greatest returns for shareholders, and we are actively engaged in evaluating and deploying funds in both pillars of these strategies as discussed herein.

As part of our expanded asset management activities, we have evaluated and continue to consider investing in various initiatives in the insurance industry across a variety of segments which we believe will produce appropriate risk-adjusted returns while maintaining the option to consider underwriting activities in the future.

1 unchanged sentence

Recent trends have increased our confidence in our recorded ultimate losses for our insurance liabilities in run-off, however a prudent assessment dictates that the run-off portfolio still requires additional maturity to fully emerge.

While there is no guarantee that these recent loss development trends will persist, as confidence increases it allows us to consider capital management initiatives.

While there is no guarantee that these recent loss development trends will persist, as confidence increases it allows us to consider continued capital management initiatives.

Our current assessment is that losses have stabilized sufficiently to consider certain capital management initiatives, although we are careful to approach these strategies in a deliberate fashion.

On November 13, 2020, as part of the capital management pillar of our strategy, the Company announced that commencing November 16, 2020, Maiden Reinsurance was offering to purchase for cash, upon the terms and subject to the conditions set forth in its Offer to Purchase and accompanying Letter of Transmittal, up to $100.0 million of its 8.25% Non-Cumulative Preference Shares Series A, 7.125% Non-Cumulative Preference Shares Series C and 6.7% Non-Cumulative Preference Shares Series D (the "Preference Securities").

There can be no assurance that our insurance liabilities will run-off at levels that will permit future capital management activities, which we expect to continually review as part of our strategy.

Please refer to the "Liquidity and Capital Resources" section for further information.

In November 2020, we formed Genesis Legacy Solutions (“GLS”) which specializes in providing a full range of legacy services to small insurance entities, particularly those in run-off or with blocks of reserves that are no longer core, working with clients to develop and implement finality solutions including acquiring entire companies.

We believe the formation of GLS is highly complementary to our overall longer-term strategy.

GLS, along with other recent insurance industry investments, enables us to leverage our knowledge base while not re-entering active underwriting of new risks and maintaining an efficient operating profile.

We believe GLS not only enhances our profitability through both fee income and effective claims management services, but it will also increase our asset base through the addition of blocks of reserves or companies that can be successfully wound down.

This should further enhance our ability to pursue the asset and capital management pillars of our business strategy.

Our ability to execute our asset and capital management initiatives is dependent on maintaining adequate levels of unrestricted liquidity and cash flows.

Further, there can be no assurance that our insurance liabilities will run-off at levels that will permit further capital management activities, which we expect to continually review as part of our strategy.

Please refer to the "Liquidity and Capital Resources" section for further information on our asset and capital management activities, in particular our various preference share repurchase measures.

COVID-19 Pandemic

2 unchanged sentences

Our results of operations, financial condition, and liquidity and capital resources have been adversely impacted by the COVID-19 pandemic, and the future impact of the pandemic on our financial condition or results of operations is difficult to predict.

As described herein, the Company is not currently engaged in active reinsurance underwriting and is running off the remaining unearned exposures it has reinsured.

As described herein, we are not currently engaged in active reinsurance underwriting and continue to run off the remaining unearned exposures we have reinsured.

Maiden Global’s business development teams partner with automobile manufacturers, dealer associations and local primary insurers to design and implement point of sale insurance programs which generate revenue for the auto manufacturer and insurance premiums for the primary insurer ("IIS unit").

Our IIS unit does write limited primary insurance coverages that could be exposed to COVID-19 claims.

Our IIS unit does write limited primary insurance coverage that could be exposed to COVID-19 claims.

While we assess our exposure to COVID-19 insurance and reinsurance claims on our existing insurance exposures and remaining reinsurance exposures as limited and immaterial, given the uncertainty surrounding the COVID-19 pandemic and its impact on the insurance industry, our preliminary estimates of loss and loss adjustment expenses ("loss and LAE") and estimates of reinsurance recoverable arising from the COVID-19 pandemic may materially change.

Maiden Reinsurance has not received any COVID-19 claims to date but our companies within our IIS unit have received a limited number of claims related to those coverages which it deems as immaterial.

Maiden Reinsurance has not received any COVID-19 claims to date but companies within our IIS unit have received a limited number of claims related to those coverages which it deems as immaterial.

Unanticipated issues relating to claims and coverage may emerge, which could adversely affect our business by increasing the scope of coverage beyond our intent and/or increasing the frequency and severity of claims.

The Company's investment portfolio may be adversely impacted by unfavorable market conditions caused by the COVID-19 pandemic and we and our reinsurance subsidiaries may need additional capital to maintain compliance with regulatory capital requirements and/or be required to post additional collateral under existing reinsurance arrangements, which could reduce our liquidity.

In addition, the Company may experience continued volatility in our results of operations which could negatively impact our financial condition and create a reduction in the amount of available distribution or dividend capacity from our regulated reinsurance subsidiaries, which would also reduce liquidity.

Please refer to the " Liquidity and Capital Resources" section for a further discussion of the impact of the COVID-19 pandemic on our liquidity and investment portfolio.

Three and Nine Months Ended September 30, 2020 and 2019 Financial Highlights

For the Three Months Ended September 30, 2020 2019 Change

Three Months Ended March 31, 2021 and 2020 Financial Highlights

For the Three Months Ended March 31, 2021 2020 Change

Summary Consolidated Statement of Income Data (unaudited):

($ in thousands except per share data)

Net income (loss) from continuing operations $ 2,162 $ (58,402) $ 60,564

Income from discontinued operations, net of income tax — 75 (75)

Net income (loss) 2,162 (58,327) 60,489

Basic and diluted earnings (loss) per common share (9) :

Net income (loss) attributable to common shareholders (2)(9)

Net income $ 9,286 $ 20,861 $ (11,575)

Gain from repurchase of preference shares 62,450 — 62,450

Net income attributable to Maiden common shareholders 71,736 20,861 50,875

Basic and diluted earnings per common share:

Net income attributable to common shareholders (2)

0.83 0.25 0.58

Gain from repurchase of preferred securities per common share 0.73 — 0.73

Gross premiums written (2,390) 11,734 (14,124)

6 unchanged sentences

Non-GAAP measures:

Non-GAAP operating (loss) earnings (1)

$ (2,313) $ 39,482 $ (41,795)

Non-GAAP basic and diluted operating (loss) earnings per common share (1)(9)

(0.03) 0.47 (0.50)

Annualized non-GAAP operating return on average common shareholders' equity (1)

(5.6) % 105.0 % (110.6)

For the Nine Months Ended September 30, 2020 2019 Change

Summary Consolidated Statement of Income Data (unaudited):

($ in thousands except per share data)

Net income (loss) from continuing operations $ 32,235 $ (88,328) $ 120,563

Loss from discontinued operations, net of income tax — (22,048) 22,048

Net income (loss) 32,235 (110,376) 142,611

Basic and diluted earnings (loss) per common share (9) :

Net income (loss) attributable to Maiden common shareholders (2)(9)

0.38 (1.33) 1.71

Gross premiums written 20,233 (523,178) 543,411

Net premiums earned 76,828 411,986 (335,158)

Underwriting loss (3)

(308) (162,075) 161,767

Net investment income 44,959 76,367 (31,408)

Combined ratio (4)

124.6 % 146.0 % (21.4)

Non-GAAP measures:

Non-GAAP operating earnings (loss) (1)

Non-GAAP operating earnings (1)

$ 47,301 $ 3,132 $ 44,169

Non-GAAP basic and diluted operating earnings (loss) per common share (1)(9)

Non-GAAP basic and diluted operating earnings per common share (1)

0.55 0.04 0.51

1 unchanged sentence

81.4 % 8.7 % 72.7

September 30, 2020 December 31, 2019 Change

March 31, 2021 December 31, 2020 Change

Consolidated Financial Condition ($ in thousands except per share data)

30 unchanged sentences

(2) Please refer to " Notes to Condensed Consolidated Financial Statements (unaudited) Note 12.

Earnings per Common Share " for the calculation of basic and diluted income or loss per common share.

Earnings per Common Share " for the calculation of basic and diluted income or income per common share.

(3) Underwriting income or loss is a non-GAAP measure and is calculated as net premiums earned plus other insurance revenue less net loss and LAE, commission and other acquisition expenses and general and administrative expenses directly related to underwriting activities.

7 unchanged sentences

See " Key Financial Measures " for additional information.

(9) During a period of loss, the basic weighted average common shares outstanding is used in the denominator of the diluted loss per common share computation as the effect of including potential dilutive shares would be anti-dilutive.

(9) Adjusted book value per common share is a non-GAAP measure that is calculated using common shareholders' equity, adjusted for the estimated unamortized deferred gain on retroactive reinsurance, divided by the number of common shares outstanding.

4 unchanged sentences

See " Key Financial Measures " for additional information.

total principal amount of debt divided by the sum of adjusted total capital resources.

(11) Ratio of debt to total capital resources is calculated using the total principal amount of debt divided by the sum of total capital resources.

6 unchanged sentences

These key financial measures are:

Non-GAAP operating earnings (loss) and non-GAAP diluted operating earnings (loss) per common share :

Management believes that the use of non-GAAP operating earnings (loss) and non-GAAP diluted operating earnings (loss) per common share enables investors and other users of the Company’s financial information to analyze its performance in a manner similar to how management analyzes performance.

Non-GAAP operating earnings and non-GAAP diluted operating earnings per common share :

Management believes that the use of non-GAAP operating earnings and non-GAAP diluted operating earnings per common share enables investors and other users of the Company’s financial information to analyze its performance in a manner similar to how management analyzes performance.

Management also believes that these measures generally follow industry practice therefore allowing the users of financial information to compare the Company’s performance with its industry peer group, and that the equity analysts and certain rating agencies which follow the Company, and the insurance industry as a whole, generally exclude these items from their analyses for the same reasons.

Non-GAAP operating earnings (loss) should not be viewed as a substitute for U.S.

GAAP net income (loss).

Non-GAAP operating earnings (loss) is an internal performance measure used by management as these measures focus on the underlying fundamentals of the Company's operations by excluding, on a recurring basis:

Non-GAAP operating earnings should not be viewed as a substitute for U.S.

GAAP net income.

Non-GAAP operating earnings is an internal performance measure used by management as these measures focus on the underlying fundamentals of the Company's operations by excluding, on a recurring basis:

(1) net realized gains or losses on investment;

2 unchanged sentences

and (4) the portion of favorable or unfavorable prior year reserve development for which we have ceded the risk under retroactive reinsurance agreements and related changes in amortization of the deferred gain liability;

It also excludes on a non-recurring basis:

(1) loss from discontinued operations, net of income tax and;

(2) interest expense paid resulting from the LPT/ADC Agreement and Commutation and Release Agreement;

(3) loss and related activity from our NGHC Quota Share run-off operations which was commuted in November 2019.

We exclude net realized gains or losses on investment, OTTI losses and foreign exchange and other gains or losses as we believe these are influenced by market opportunities and other factors.

We do not believe results from our NGHC Quota Share run-off operations commuted in November 2019 and results from our discontinued operations, (2) interest expense paid on the LPT/ADC Agreement and Commutation and Release Agreement and ceded risks under retroactive reinsurance agreements are representative of our ongoing and future business.

and (5) interest in income of equity method investments.

We have excluded net realized gains on investment, OTTI losses, interest in income of equity method investments and foreign exchange and other gains as we believe these are influenced by market opportunities and other factors.

We do not believe that ceded risks under retroactive reinsurance agreements are representative of our ongoing and future business.

We believe all of these amounts are substantially independent of our business and any potential future underwriting process therefore including them would distort the analysis of underlying trends in our operations.

10 unchanged sentences

A combined ratio under 100% indicates underwriting profitability, as the net loss and LAE, commission and other acquisition expenses and general and administrative expenses are less than the net premiums earned and other insurance revenue on that business.

While the Company has continued to utilize this non-GAAP measure in this Quarterly Report on Form 10-Q for the three and nine months ended September 30, 2020, as the run-off of our reinsurance portfolios progresses, such ratios may increasingly be of less value to readers as they evaluate the financial results of the Company, particularly compared to historical data.

While the Company has continued to utilize this non-GAAP measure in this Quarterly Report on Form 10-Q for the three months ended March 31, 2021, it is important to note that as the run-off of our reinsurance portfolios progresses, such ratios may increasingly be of less value to readers as they evaluate the financial results of the Company, particularly compared to historical data.

Please refer to " Notes to Condensed Consolidated Financial Statements (unaudited) Note 3.

Segment Information " included under Item 1.

Segment Information " under Item 1.

"Financial Statements" of this Quarterly Report on Form 10-Q for further details.

11 unchanged sentences

Book value per common share and diluted book value per common share are non-GAAP measures.

Management uses growth in both of these metrics as a prime measure of the value we are generating for our common shareholders, because management believes that growth in each metric ultimately results in growth in the Company’s common share price.

These metrics are impacted by the Company’s net income and external factors, such as interest rates, which can drive changes in unrealized gains or losses on our investment portfolio, as well as share repurchases.

Management uses growth in both of these metrics as a prime measure

of the value we are generating for our common shareholders, because management believes that growth in each metric ultimately results in growth in the Company’s common share price.

These metrics are impacted by the Company’s net income and external factors, such as interest rates, which can drive changes in unrealized gains or losses on our fixed income investment portfolio, as well as common or preferred share repurchases.

Ratio of Debt to Total Capital Resources:

1 unchanged sentence

This measure is calculated using the total principal amount of debt divided by the sum of total capital resources.

Non-GAAP underwriting income (loss), Non-GAAP earnings (loss) and LAE ratio, and Non-GAAP combined ratio:

Non-GAAP underwriting income (loss), Non-GAAP loss and LAE ratio, and Non-GAAP combined ratio:

Management has further adjusted underwriting loss, as defined above, as well as the reported loss and LAE ratios and reported combined ratios by excluding the portion of favorable or unfavorable prior year reserve development for which we have ceded the risk under retroactive reinsurance agreements such as the LPT/ADC Agreement.

These losses are estimated to be fully recoverable from Cavello and management believes adjusting for this shows the ultimate economic benefit of the LPT/ADC Agreement on the Company's underwriting results.

These losses are estimated to be fully recoverable from Cavello and management believes adjusting for this development shows the ultimate economic benefit of the LPT/ADC Agreement on our underwriting results.

We believe reflecting the economic benefit of this retroactive reinsurance agreement is helpful for understanding future trends in our operations.

8 unchanged sentences

Certain Operating Measures

Refer to " Management's Discussion and Analysis of Financial Condition and Results of Operations " section included under Item 7 of our Annual Report on Form 10-K for the year ended December 31, 2019 for a general discussion on " Certain Operating Measures" utilized by the Company.

Refer to " Management's Discussion and Analysis of Financial Condition and Results of Operations " section included under Item 7 of our Annual Report on Form 10-K for the year ended December 31, 2020, filed with the SEC on March 15, 2021, for a general discussion on " Certain Operating Measures" utilized by the Company.

Critical Accounting Policies and Estimates

5 unchanged sentences

Results of Operations

The following table sets forth our selected unaudited Condensed Consolidated Statement of Income data for three and nine months ended September 30, 2020 and 2019:

For the Three Months Ended September 30, For the Nine Months Ended September 30,

The following table sets forth our selected unaudited Condensed Consolidated Statement of Income data for the three months ended March 31, 2021 and 2020:

For the Three Months Ended March 31,

($ in thousands) 2021 2020

6 unchanged sentences

Other insurance revenue

261 554 919 2,120

Net loss and LAE

9 unchanged sentences

Net investment income

12,686 13,223 44,959 76,367

Net realized gains on investment

4,133 12,700 24,046 25,685

Total other-than-temporary impairment losses

(962) (165) (2,468) (165)

Foreign exchange and other (losses) gains (6,536) 7,827 (634) 14,013

Foreign exchange and other gains 3,542 8,197

Interest and amortization expenses (4,831) (4,831)

Income tax (expense) benefit (17) (87) (14) 977

Net income (loss) from continuing operations

2,162 (58,402) 32,235 (88,328)

Income (loss) from discontinued operations, net of income tax — 75 — (22,048)

Net income (loss)

$ 2,162 $ (58,327) $ 32,235 $ (110,376)

Income tax expense (49) (15)

Interest in income of equity method investments 2,947 —

Net income 9,286 20,861

Gain from repurchase of preference shares 62,450 —

Net income available to Maiden common shareholders $ 71,736 $ 20,861

Net loss and LAE ratio (3)

10 unchanged sentences

Please refer to "General and Administrative Expenses" below for additional information related to these corporate expenses and the reconciliation to those presented in our unaudited Condensed Consolidated Statements of Income.

(2) Underwriting loss is a non-GAAP measure and is calculated as net premiums earned plus other insurance revenue less net loss and LAE, commission and other acquisition expenses and general and administrative expenses directly related to underwriting activities.

(2) Underwriting income (loss) is a non-GAAP measure and is calculated as net premiums earned plus other insurance revenue less net loss and LAE, commission and other acquisition expenses and general and administrative expenses directly related to underwriting activities.

(3) Calculated by dividing net loss and LAE by the sum of net premiums earned and other insurance revenue.

3 unchanged sentences

(7) Calculated by adding together net loss and LAE ratio and the expense ratio.

Net Income (Loss)

Net income for the three months ended September 30, 2020 was $2.2 million compared to a net loss of $58.3 million for the same period in 2019.

The net improvement in results for the three months ended September 30, 2020 compared to the same period in 2019 was primarily due to the following:

• net income from continuing operations of $2.2 million compared to net loss from continuing operations of $58.4 million for the same period in 2019 largely due to the following factors:

• underwriting income of $3.4 million for the three months ended September 30, 2020 compared to an underwriting loss of $80.3 million in the same period in 2019.

The improvement in the underwriting income was due to:

◦ the impact of lower loss ratios for current year premiums earned during the three months ended September 30, 2020 compared to the same period in 2019;

◦ favorable prior year loss development of $7.2 million or 29.5 percentage points in the third quarter of 2020 compared to adverse prior year loss development of $63.2 million or 66.2 percentage points during the same period in 2019 which had been incurred primarily within AmTrust Reinsurance Segment.

The improvement in our underwriting results was partially offset by the following:

• lower realized gains on investment of $4.1 million for the three months ended September 30, 2020 compared to realized gains of $12.7 million for the same period in 2019;

• a reduction in net investment income of $0.5 million or 4.1% for the three months ended September 30, 2020 compared to the same period in 2019 primarily due to the decline in average investable assets of 34.1%;

• foreign exchange and other losses of $6.5 million for the three months ended September 30, 2020 compared to foreign exchange and other gains of $7.8 million for the same period in 2019.

Net income for the nine months ended September 30, 2020 was $32.2 million compared to a net loss of $110.4 million for the same period in 2019.

The net improvement in results for the nine months ended September 30, 2020 compared to the same period in 2019 was primarily due to the following:

• net income from continuing operations of $32.2 million compared to net loss from continuing operations of $88.3 million for the same period in 2019 largely due to the following factors:

• underwriting loss of $0.3 million compared to $162.1 million in the same period in 2019.

The reduction in the underwriting loss was due to:

◦ the impact of lower loss ratios for current year premiums earned during the nine months ended September 30, 2020 compared to the same period in 2019;

◦ favorable prior year loss development of $7.8 million or 10.1 percentage points in the nine months ended September 30, 2020 compared to adverse prior year loss development of $96.5 million or 23.3 percentage points during the same period in 2019 which had been incurred primarily within AmTrust Reinsurance Segment.

The improvement in our underwriting results was partially offset by the following:

• a reduction in net investment income of $31.4 million or 41.1% for the nine months ended September 30, 2020 compared to the same period in 2019, primarily due to the decline in average investable assets of 34.2%;

• lower realized gains on investment of $24.0 million for the nine months ended September 30, 2020 compared to realized gains of $25.7 million for the same period in 2019;

• foreign exchange and other losses of $0.6 million for the nine months ended September 30, 2020 compared to foreign exchange and other gains of $14.0 million for the same period in 2019.

• net income from discontinued operations of $0.0 million for the nine months ended September 30, 2020 compared to a net loss from discontinued operations of $22.0 million for the same period in 2019 as a result of the Settlement and Commutation Agreement entered into by the Company and Enstar on July 31, 2019 which caused a net additional loss of $16.7 million to be recognized.

Net income available to Maiden common shareholders for the three months ended March 31, 2021 was $71.7 million compared to $20.9 million for the same period in 2020.

The net improvement in results for the three months ended March 31, 2021 compared to the same period in 2020 was primarily due to the following:

• gain from repurchase of preference shares of $62.5 million for the three months ended March 31, 2021 resulting from the 2021 Preference Share Repurchase;

• interest in income of equity method investments of $2.9 million for the three months ended March 31, 2021 which were newly acquired in the third quarter of 2020;

• net income of $9.3 million compared to net income of $20.9 million for the same respective period in 2020 largely due to the following factors:

• underwriting income of $1.6 million for the three months ended March 31, 2021 compared to an underwriting loss of $3.7 million in the same period in 2020.

The improvement in underwriting income was driven by favorable prior year loss development of $5.6 million or 46.2 percentage points in the first quarter of 2021 compared to favorable prior year loss development of $0.5 million or 1.7 percentage points during the same period in 2020 due to favorable prior year loss development in the AmTrust Reinsurance segment in the first quarter of 2021.

The improvement in our underwriting results was partially offset by the following variances:

• a reduction in realized gains on investment of $2.9 million for the three months ended March 31, 2021 compared to the same period in 2020;

• a reduction in net investment income of $8.1 million or 45.2% for the three months ended March 31, 2021 compared to the same period in 2020 primarily due to the decline in average investable assets of 21.4%;

• a reduction in foreign exchange and other gains of $4.7 million for the three months ended March 31, 2021 compared to the same period in 2020.

Net Premiums Written

The tables below compare net premiums written by our reportable segments, reconciled to the total consolidated net premiums written for the three and nine months ended September 30, 2020 and 2019:

For the Three Months Ended September 30, 2020 2019 Change in

($ in thousands) Total Total $ %

Diversified Reinsurance

$ 8,666 $ 14,539 $ (5,873) (40.4) %

AmTrust Reinsurance (5,635) 21,405 (27,040) (126.3) %

Total $ 3,031 $ 35,944 $ (32,913) (91.6) %

For the Nine Months Ended September 30, 2020 2019 Change in

The table below compares net premiums written by our reportable segments, reconciled to the total consolidated net premiums written for the three months ended March 31, 2021 and 2020:

For the Three Months Ended March 31, 2021 2020 Change in

($ in thousands) Total Total $ %

1 unchanged sentence

$ (234) $ 10,372 $ (10,606) (102.3) %

AmTrust Reinsurance (10,098) (564,199) 554,101 (98.2) %

AmTrust Reinsurance (2,462) — (2,462) NM

Total $ (2,696) $ 10,372 $ (13,068) (126.0) %

Net premiums written for the three and nine months ended September 30, 2020 were $3,031 and $17,493, respectively, compared to net premiums written of $35,944 and $(525,995) in the same respective periods in 2019 due to the following:

• Premiums written in the Diversified Reinsurance segment decreased by $5.9 million or 40.4% and $10.6 million or 27.8% for the three and nine months ended September 30, 2020, respectively, compared to the same respective periods in 2019 due to lower premiums written in German Auto programs within our IIS business.

NM - not meaningful

Net premiums written for the three months ended March 31, 2021 decreased to $(2,696) compared to net premiums written of $10,372 in the same respective period in 2020 due to the following:

• Premiums written in the Diversified Reinsurance segment decreased by $10.6 million or 102.3% for the three months ended March 31, 2021 compared to the same respective period in 2020 due to the return of unearned premiums after the non-renewal of the German Auto Programs reinsurance contract in our IIS business on January 1, 2021.

• There were no new written premiums within the AmTrust Reinsurance segment due to the termination of both the AmTrust Quota Share and the European Hospital Liability Quota Share effective January 1, 2019.

For the three and nine months ended September 30, 2020 and 2019, the negative premiums written are primarily the result of return premium and other adjustments after the termination of the AmTrust contracts in 2019.

In 2019, the Partial Termination Amendment resulted in Maiden Reinsurance returning approximately $648.0 million in unearned premium to AII, or $436.8 million net of applicable ceding commission and brokerage.

Negative premiums for the three months ended March 31, 2021 were due to premium adjustments on Small Commercial Business policies.

Please refer to the analysis below of our Diversified Reinsurance and AmTrust Reinsurance segments for further details.

Net Premiums Earned

Net premiums earned decreased by $70.6 million or 74.4% and $335.2 million or 81.4% for the three and nine months ended September 30, 2020, respectively, compared to the same respective periods in 2019.

The tables below compare net premiums earned by our reportable segments, reconciled to the total consolidated net premiums earned, for the three and nine months ended September 30, 2020 and 2019:

For the Three Months Ended September 30, 2020 2019 Change in

($ in thousands) Total % of Total Total % of Total $ %

Diversified Reinsurance

$ 11,323 46.6 % $ 20,492 21.6 % $ (9,169) (44.7) %

AmTrust Quota Share Reinsurance

12,982 53.4 % 74,406 78.4 % (61,424) (82.6) %

$ 24,305 100.0 % $ 94,898 100.0 % $ (70,593) (74.4) %

For the Nine Months Ended September 30, 2020 2019 Change in

Net premiums earned decreased by $19.5 million or 62.3% for the three months ended March 31, 2021, compared to the same respective period in 2020.

The table below compares net premiums earned by our reportable segments, reconciled to the total consolidated net premiums earned, for the three months ended March 31, 2021 and 2020:

For the Three Months Ended March 31, 2021 2020 Change in

($ in thousands) Total % of Total Total % of Total $ %

4 unchanged sentences

$ 11,764 100.0 % $ 31,215 100.0 % $ (19,451) (62.3) %

Net premiums earned in the AmTrust Reinsurance segment for the three and nine months ended September 30, 2020 decreased by $61.4 million or 82.6% and $302.3 million or 87.9%, respectively, compared to the same respective periods in 2019 due to the terminations of the AmTrust Quota Share and European Hospital Liability Quota Share effective January 1, 2019.

Net premiums earned in the AmTrust Reinsurance segment for the three months ended March 31, 2021 decreased by $13.2 million or 70.4% compared to the same respective period in 2020 due to termination of the AmTrust Quota Share and European Hospital Liability Quota Share effective January 1, 2019.

Please refer to the analysis of our AmTrust Reinsurance segment for further discussion.

Net premiums earned in our Diversified Reinsurance segment for the three and nine months ended September 30, 2020 decreased by $9.2 million or 44.7% and $32.9 million or 48.2%, respectively, compared to the same respective periods in 2019 driven by non-renewals in our European Capital Solutions business combined with reductions in quota share cessions for German Auto Programs within our IIS business.

Net premiums earned in our Diversified Reinsurance segment for the three months ended March 31, 2021 decreased by $6.3 million or 50.2% compared to the same respective period in 2020 due to German Auto programs quota share reinsurance contract which went into run-off on January 1, 2021 in our IIS business.

Please refer to the analysis of our Diversified Reinsurance segment for further discussion.

3 unchanged sentences

Net Investment Income

Net investment income decreased by $0.5 million or 4.1% and $31.4 million or 41.1% for the three and nine months ended September 30, 2020, respectively, compared to the respective periods in 2019, primarily due to the decline in average investable assets of 34.1% and 34.2% in those same respective periods.

The decrease in investable assets is largely due to the cessation of active reinsurance underwriting which materially reduced our revenues resulting in significant negative operating cash flows as we run-off our existing reinsurance liabilities.

During the three and nine months ended September 30, 2019, the Company paid AmTrust and Enstar an aggregate of $13.6 million for interest due on the settlement of funding for amounts related to the Commutation and Release Agreement and the LPT/ADC Agreement, respectively.

Excluding this non-recurring interest expense, average book yields were 2.9% and 3.1% for the three and nine months ended September 30, 2019, respectively, compared to average book yields of 2.1% and 2.3% for the same respective periods in 2020.

The following table details the Company's average investable assets and average book yield for the three and nine months ended September 30, 2020 compared to the same respective periods in 2019:

For the Three Months Ended September 30, For the Nine Months Ended September 30,

Net investment income decreased by $8.1 million or 45.2% for the three months ended March 31, 2021 compared to the same period in 2020 largely due to the decline in average investable assets of 21.4%.

The decline in investable assets is driven by the cessation of active reinsurance underwriting which materially reduced our revenues resulting in significant negative operating cash flows as we run-off our existing reinsurance liabilities.

Net investment income also decreased due to the decline in average book yields to 1.9% for the three months ended March 31, 2021 compared to 2.7% for the three months ended March 31, 2020, which is the result of both lower interest rates and shorter duration of assets in our fixed income portfolios.

The following table details our average invested assets and book yield for the three months ended March 31, 2021 and 2020:

For the Three Months Ended March 31,

($ in thousands) 2021 2020

Average investable assets (1)

Average invested assets (1)

$ 2,127,063 $ 2,705,803

Average book yield (2)

2.1 % 1.4 % 2.3 % 2.6 %

Adjusted average book yield (3)

2.1 % 2.9 % 2.3 % 3.1 %

(1) The average of our total investments, cash, restricted cash and cash equivalents, funds withheld receivable and loan to related party held at each quarter-end during the period.

(2) Ratio of net investment income over average investable assets at fair value.

(3) Ratio of net investment income, excluding the interest payments to AmTrust and Enstar, over average investable assets at fair value, as adjusted.

(1) The average of our total investments (excluding equity method investments), cash, restricted cash and cash equivalents, funds withheld receivable and loan to related party held at each quarter-end during the period.

(2) Ratio of net investment income over average invested assets at fair value.

Net Realized Gains on Investment

Net realized gains on investment were $4.1 million and $24.0 million for the three and nine months ended September 30, 2020, respectively, compared to net realized gains of $12.7 million and $25.7 million for the same respective periods in 2019.

The realized gains for the three and nine months ended September 30, 2020 were primarily due to sales of corporate bonds during 2020 for the settlement of claim payments to AmTrust.

The net realized gains on investment of $12.7 million and $25.7 million for the same respective periods in 2019 were the result of sales of corporate bonds in anticipation of completing and funding the LPT/ADC Agreement with Enstar as well as sales of corporate bonds during the third quarter for the settlement of the Commutation Payment to AmTrust via transfer of cash and invested assets on August 12, 2019.

The year-to-date gains were partially offset by net investment losses realized on the non-cash transfer of corporate and other debt securities in early 2019 related to the Partial Termination Amendment with AmTrust and the conversion of a portion of reinsurance trust assets held as collateral into a funds withheld receivable.

Net realized gains on investment were $8.1 million for the three months ended March 31, 2021, compared to net realized gains of $11.0 million for the same respective period in 2020.

Net realized gains for the three months ended March 31, 2021 include the recognition of $4.5 million in unrealized gains related to an investment in an insurtech start-up company that was acquired by a special purpose acquisition company.

In addition, realized gains for the three months ended March 31, 2021 and 2020 also reflect sales of corporate bonds for the settlement of claim payments to AmTrust.

Net Impairment Losses Recognized in Earnings

The Company recognized $1.0 million and $2.5 million of OTTI losses on two and four fixed maturity securities for the three and nine months ended September 30, 2020, respectively, compared to $0.2 million of OTTI losses on one fixed maturity security for the three and nine months ended September 30, 2019.

The Company did not recognize any OTTI losses on its fixed maturity portfolio for the three months ended March 31, 2021 compared to $1.5 million of OTTI losses recorded on two fixed maturity securities for the three months ended March 31, 2020.

Interest in Income of Equity Method Investments

The Company recognized interest in income of equity method investments of $2.9 million for the year ended March 31, 2021.

These investments include hedge fund investments of $31.1 million which were newly acquired in the third quarter of 2020.

Net Loss and LAE

Net loss and LAE decreased by $131.8 million and $374.0 million during the three and nine months ended September 30, 2020, respectively, compared to the same respective periods in 2019 largely due to the cessation of active reinsurance underwriting, including the termination of the AmTrust Reinsurance quota share agreements effective January 1, 2019.

The loss ratio for the third quarter of 2020 was impacted by net favorable prior year reserve development of $7.2 million or 29.5 percentage points compared to net adverse prior year reserve development of $63.2 million or 66.2 percentage points during the same period in 2019.

The loss ratio for the nine months ended September 30, 2020 was impacted by net favorable prior year reserve development of $7.8 million or 10.1 percentage points compared to net adverse prior year reserve development of $96.5 million or 23.3 percentage points during the same period in 2019.

Net loss and LAE decreased by $18.7 million during the three months ended March 31, 2021 compared to the same respective period in 2020 largely due to favorable prior year reserve development of $5.6 million for the first quarter of 2021.

The loss ratio for the first quarter of 2021 was impacted by net favorable prior year reserve development of $5.6 million or 46.2 percentage points compared to net favorable prior year reserve development of $0.5 million or 1.7 percentage points during the same period in 2020.

The prior year development is discussed in greater detail in the individual segment discussion and analysis.

The net loss and LAE ratios decreased to 36.9% and 52.9% for the three and nine months ended September 30, 2020, respectively, compared to 147.6% and 100.2% for the same respective periods in 2019 primarily due to significant reduction in adverse prior year loss development resulting from the termination of the AmTrust Reinsurance quota share contracts effective January 1, 2019.

The net loss and LAE ratios decreased to 19.6% for the three months ended March 31, 2021 compared to 66.7% for the same respective period in 2020 due to significant favorable prior year loss experience in the AmTrust Reinsurance segment that developed in the first quarter of 2021.

Commission and Other Acquisition Expenses

Commission and other acquisition expenses decreased by $23.1 million or 70.5% and $122.3 million or 80.4% for the three and nine months ended September 30, 2020, respectively, compared to the same respective periods in 2019 due to significantly lower earned premiums in both of our reportable segments.

The commission and other acquisition expense ratio increased to 39.3% and 38.3% for the three and nine months ended September 30, 2020, respectively, compared to 34.3% and 36.7% for the same respective periods in 2019.

Commission and other acquisition expenses decreased by $6.0 million or 50.4% for the three months ended March 31, 2021, compared to the same respective period in 2020.

The commission and other acquisition expense ratio increased to 49.4% for the three months ended March 31, 2021 compared to 37.9% for the same respective period in 2020 largely due to a change in mix of premiums written in our Diversified Reinsurance segment.

General and Administrative Expenses

General and administrative expenses include both segment and corporate expenses which are segregated for analytical purposes as a component of underwriting income.

General and administrative expenses for the three and nine months ended September 30, 2020 and 2019 comprise:

For the Three Months Ended September 30, For the Nine Months Ended September 30,

General and administrative expenses, which include both segment and corporate expenses segregated for analytical purposes as a component of underwriting income, for the three months ended March 31, 2021 and 2020 were comprised of:

For the Three Months Ended March 31,

($ in thousands) 2021 2020

2 unchanged sentences

General and administrative expenses – corporate

5,712 6,814 18,853 28,640

Total general and administrative expenses

$ 13,997 $ 8,550

Total general and administrative expenses decreased by $0.7 million, or 8.3% and $11.7 million or 31.1% for the three and nine months ended September 30, 2020, respectively, compared to the same respective periods in 2019.

The general and administrative expense ratio increased to 33.2% and 33.4% for the three and nine months ended September 30, 2020, respectively, from 9.3% and 9.1% for the three and nine months ended September 30, 2019 as a result of significantly lower earned premiums compared to the prior periods.

Lower earned premiums was largely due to termination of the AmTrust Reinsurance quota share contracts effective January 1, 2019 and non-renewals within our International business in the Diversified Reinsurance segment.

The decreased corporate expenses for the three and nine months ended September 30, 2020 compared to the same respective periods in 2019 were largely due to lower salary, benefits and other corporate expenses associated with the Strategic Review and related headcount reductions since 2018.

Total general and administrative expenses increased by $5.4 million, or 63.7% for the three months ended March 31, 2021, compared to the same respective period in 2020.

Corporate general and administrative expenses for the three months ended March 31, 2021 increased by $5.5 million or 87.8% compared to the same respective period in 2020 due to higher equity-based and cash incentive compensation paid to employees in the first quarter of 2021.

Interest and Amortization Expenses

The interest and amortization expenses related to the outstanding senior notes issued by Maiden Holdings in 2016 and Maiden NA in 2013 ("Senior Notes") were $4.8 million and $14.5 million for the three and nine months ended September 30, 2020 and 2019, respectively.

The interest and amortization expenses related to the outstanding senior notes issued by Maiden Holdings in 2016 and Maiden NA in 2013 ("Senior Notes") were $4.8 million for the three months ended March 31, 2021 and 2020, respectively.

Please refer to " Notes to Condensed Consolidated Financial Statements (unaudited) Note 7.

Long Term Debt " for further details on the Senior Notes.

The weighted average effective interest rate for the Senior Notes was 7.6% for the three and nine months ended September 30, 2020 and 2019, respectively.

Foreign Exchange and Other (Losses) Gains

Net foreign exchange and other losses amounted to $6.5 million and $0.6 million during the three and nine months ended September 30, 2020, respectively, compared to net foreign exchange and other gains of $7.8 million and $14.0 million for the same respective periods in 2019.

Net foreign exchange losses of $6.5 million and $0.2 million occurred during the three and nine months ended September 30, 2020, respectively, due to the weakening of the U.S.

dollar on the re-measurement of net loss reserves and related liabilities denominated in British pound and euro.

Net foreign exchange and other gains of $14.0 million for the nine months ended September 30, 2019 included $4.3 million of proceeds received from the sale of AVS and its related European subsidiaries to Allianz Partners on January 10, 2019.

Excluding the gain of $4.3 million, net foreign exchange gains of $9.7 million were realized primarily attributable to the strengthening of the U.S.

dollar on the re-measurement of net loss reserves and related liabilities denominated in British pound and euro.

The weighted average effective interest rate for the Senior Notes was 7.6% for the three months ended March 31, 2021 and 2020, respectively.

Foreign Exchange and Other Gains

Net foreign exchange and other gains amounted to $3.5 million during the three months ended March 31, 2021 compared to net foreign exchange and other gains of $8.2 million for the same respective period in 2020.

Net foreign exchange gains of $3.4 million occurred during the three months ended March 31, 2021 largely due to the strengthening of the U.S.

dollar on the re-measurement of net loss reserves and insurance related liabilities denominated in euro.

Net foreign exchange gains of $8.4 million for the three months ended March 31, 2020 were attributable to the strengthening of the U.S.

dollar on the re-measurement of net loss reserves and insurance related liabilities denominated in pound sterling and euro.

Underwriting Results by Reportable Segment

Diversified Reinsurance Segment

The underwriting results and associated ratios for our Diversified Reinsurance segment for the three and nine months ended September 30, 2020 and 2019 were as follows:

For the Three Months Ended September 30, For the Nine Months Ended September 30,

The underwriting results and associated ratios for our Diversified Reinsurance segment for the three months ended March 31, 2021 and 2020 were as follows:

For the Three Months Ended March 31,

($ in thousands) 2021 2020

6 unchanged sentences

Other insurance revenue

261 554 919 2,120

Net loss and LAE

15 unchanged sentences

103.6 % 105.4 %

The combined ratio for the three and nine months ended September 30, 2020 increased to 109.2% and 105.9%, respectively, compared to 107.7% and 102.4% for the same respective periods in 2019, largely due to significant declines in earned premium volume which increased the expense ratio and more than offset lower loss and LAE ratios.

The combined ratio for the three months ended March 31, 2021 decreased to 103.6%, compared to 105.4% for the same respective period in 2020 largely due to significant declines in earned premium volume that increased the expense ratio which was offset by lower loss ratios.

Please see the respective sections on net loss, commissions and administrative expenses for factors that have impacted the combined ratios in the discussion below.

Premiums — Gross premiums written decreased by $5.3 million or 36.6% and $10.4 million or 25.5% for the three and nine months ended September 30, 2020, respectively, compared to the same respective periods in 2019.

This was primarily due to lower premiums written in German Auto Programs in our IIS business during the three and nine months ended September 30, 2020.

Net premiums written decreased by $5.9 million or 40.4% and $10.6 million or 27.8% during the three and nine months ended September 30, 2020 compared to the same respective periods in 2019 mainly due to lower net premiums written in our German Auto programs within our IIS business as discussed above.

The tables below show net premiums written by line of business for the three and nine months ended September 30, 2020 and 2019:

For the Three Months Ended September 30, 2020 2019 Change in

($ in thousands) Total Total $ %

Net Premiums Written

International

$ 8,757 $ 14,563 $ (5,806) (39.9) %

(91) (24) (67) NM

Total Diversified Reinsurance

$ 8,666 $ 14,539 $ (5,873) (40.4) %

For the Nine Months Ended September 30, 2020 2019 Change in

Premiums — Gross premiums written decreased by $11.7 million or 99.4% for the three months ended March 31, 2021, compared to the same respective period in 2020.

This was primarily due to the return of unearned premiums written in a German Auto quota share reinsurance contract in our IIS business which went into run-off on January 1, 2021.

While gross premiums written on primary policies in our IIS business only decreased by $0.2 million or 3.7% for the three months ended March 31, 2021 compared to the same respective period in 2020, net premiums written increased by $1.0 million or 26.1% due to organic growth in Maiden GF and Maiden LF that is not reinsured as flat gross premiums written largely due to loss of program that was 90% reinsured.

Net premiums written decreased by $10.6 million or 102.3% during the three months ended March 31, 2021 compared to the same respective period in 2020 due to return of unearned premiums written in our German Auto quota share reinsurance contract which went into run-off on January 1, 2021.

The table below shows net premiums written by line of business for the three months ended March 31, 2021 and 2020:

For the Three Months Ended March 31, 2021 2020 Change in

($ in thousands) Total Total $ %

2 unchanged sentences

$ (244) $ 10,372 $ (10,616) (102.4) %

(36) (42) 6 (14.3) %

Total Diversified Reinsurance

1 unchanged sentence

NM - not meaningful

Net premiums earned decreased by $9.2 million or 44.7% and $32.9 million or 48.2% during the three and nine months ended September 30, 2020, respectively, compared to the same respective periods in 2019 primarily due to lower earned premiums from German Auto programs and non-renewals in our European Capital Solutions business since 2019.

The tables below show net premiums earned by line of business for the three and nine months ended September 30, 2020 and 2019:

For the Three Months Ended September 30, 2020 2019 Change in

($ in thousands) Total Total $ %

Net Premiums Earned

International

$ 11,414 $ 20,516 $ (9,102) (44.4) %

(91) (24) (67) NM

Total Diversified Reinsurance

$ 11,323 $ 20,492 $ (9,169) (44.7) %

For the Nine Months Ended September 30, 2020 2019 Change in

Net premiums earned decreased by $6.3 million or 50.2% during the three months ended March 31, 2021 compared to the same respective period in 2020 primarily due to lower earned premiums from German Auto programs which is in run-off as of January 1, 2021.

The table below shows net premiums earned by line of business for the three months ended March 31, 2021 and 2020:

For the Three Months Ended March 31, 2021 2020 Change in

($ in thousands) Total Total $ %

2 unchanged sentences

$ 6,230 $ 12,531 $ (6,301) (50.3) %

(36) (42) 6 (14.3) %

Total Diversified Reinsurance

1 unchanged sentence

NM - not meaningful

Other Insurance Revenue — Other insurance revenue, which represents fee income from our IIS business that is not directly associated with premium revenue assumed by the Company as well as other income earned from transitional services relating to the sale of Maiden US, decreased by $0.3 million or 52.9% and $1.2 million or 56.7% for the three and nine months ended September 30, 2020, respectively, compared to the same respective periods in 2019.

This was partly due to the sale of AVS and its subsidiaries on January 10, 2019 as a substantial portion of our International fee income was generated by AVS and its subsidiaries in Germany and Austria through its point of sale producers in select OEM's dealerships.

The tables below show other insurance revenue by source for the three and nine months ended September 30, 2020 and 2019:

For the Three Months Ended September 30, 2020 2019 Change

($ in thousands)

International $ 197 $ 302 $ (105) (34.8) %

Other income 64 252 (188) (74.6) %

Total Diversified Reinsurance $ 261 $ 554 $ (293) (52.9) %

For the Nine Months Ended September 30, 2020 2019 Change

Other Insurance Revenue — Other insurance revenue represents fee income from our IIS business that is not directly associated with premium revenue assumed by the Company as well as other income earned from transitional services relating to the sale of Maiden US.

Such revenue decreased by $0.1 million or 34.1% for the three months ended March 31, 2021 compared to the same respective period in 2020 partly due to the end of transitional services provided on behalf of Maiden US.

The tables below show other insurance revenue by source for the three months ended March 31, 2021 and 2020:

For the Three Months Ended March 31, 2021 2020 Change

($ in thousands)

2 unchanged sentences

Total Diversified Reinsurance $ 269 $ 408 $ (139) (34.1) %

Net Loss and LAE — Net loss and LAE decreased by $7.2 million or 52.0% and $21.0 million or 51.6% for the three and nine months ended September 30, 2020, respectively, compared to the same respective periods in 2019.

Net loss and LAE ratio decreased to 57.2% and 54.3% for the three and nine months ended September 30, 2020, respectively, compared with 65.6% and 57.8% during the same respective periods in 2019.

During the three months ended September 30, 2020, the net loss and LAE ratio decreased by 8.4 percentage points compared to the same period in 2019.

The 2020 loss ratio was impacted by adverse prior year loss reserve development which was $0.5 million or 4.2 percentage points during the three months ended September 30, 2020, compared to the impact of adverse development of $0.7 million or 3.3 percentage points on the loss ratio for the same period in 2019.

The loss development in 2020 was due to adverse development experienced in European Capital Solutions while the loss development in 2019 was the result of adverse development experienced in facultative reinsurance run-off partially offset by favorable development in International Auto.

During the nine months ended September 30, 2020, the net loss and LAE ratio decreased by 3.5 percentage points compared to the same period in 2019.

The 2020 loss ratio was impacted by adverse prior year loss reserve development which was $0.3 million or 0.9 percentage points during the nine months ended September 30, 2020, compared to the impact of favorable development of $1.5 million or 2.1 percentage points on the loss ratio in 2019.

The adverse loss development in 2020 was the

result of adverse development experienced in European Capital Solutions, while the favorable loss development in 2019 was due to favorable development experienced from facultative reinsurance run-off lines as well as German Auto programs.

Net Loss and LAE — Net loss and LAE decreased by $5.6 million or 79.9% for the three months ended March 31, 2021 compared to the same respective period in 2020.

Net loss and LAE ratio decreased to 21.7% for the three months ended March 31, 2021 compared with 54.4% during the same respective period in 2020.

During the three months ended March 31, 2021, the net loss and LAE ratio decreased by 32.7 percentage points compared to the same period in 2020.

The 2021 loss ratio was impacted by adverse prior year loss reserve development which was $14.0 thousand or 0.2 percentage points during the three months ended March 31, 2021 compared to the impact of favorable development of $0.5 million or 4.1 percentage points on the loss ratio for the same period in 2020.

The loss development in 2021 was due to adverse development experienced in European Capital Solutions and other run-off business while the loss development in 2020 was driven by favorable experience in our German Auto quota share reinsurance contract.

The impact on the net loss and LAE ratios should be considered in conjunction with the commission and other acquisition expense ratio as changes to either ratio can be effected by changes in the mix of business and the impact of increases in the commission and other acquisition expense rates on pro-rata contracts with loss sensitive features.

As a result of these factors, as well as the impact on the loss ratio described above, the combined ratio increased by 1.5 and 3.5 percentage points for the three and nine months ended September 30, 2020 compared to the same respective periods in 2019.

Commission and Other Acquisition Expenses — Commission and other acquisition expenses decreased by $2.8 million or 40.0% and $10.9 million or 44.5% for the three and nine months ended September 30, 2020, respectively, compared to the same respective periods in 2019, largely as a result of the corresponding decrease in net premiums earned in this segment.

The commission and other acquisition expense ratio for the three and nine months ended September 30, 2020 increased to 36.3% and 37.3%, respectively, compared to 33.3% and 34.7% for the same respective periods in 2019, reflecting the change in the mix of pro rata versus excess of loss premiums written compared to the same respective periods in 2019.

As a result of these factors, as well as the impact on the loss ratio described above, the combined ratio decreased by 1.8 percentage points for the three months ended March 31, 2021 compared to the same respective period in 2020.

Commission and Other Acquisition Expenses — Commission and other acquisition expenses decreased by $1.2 million or 24.6% for the three months ended March 31, 2021 compared to the same respective period in 2020 primarily due to the corresponding amount of net premiums earned which similarly decreased in this segment.

The commission and other acquisition expense ratio for the three months ended March 31, 2021 increased to 57.7% compared to 38.5% for the same respective period in 2020, reflecting the change in the mix of pro rata versus excess of loss premiums written compared to the same respective periods in 2020.

Please refer to the preceding paragraph for other factors that can impact the combined ratio.

General and Administrative Expenses — General and administrative expenses decreased by 1.7% and $1.8 million or 25.7% for the three and nine months ended September 30, 2020, respectively, compared to the same respective periods in 2019.

The general and administrative expense ratio increased to 15.7% and 14.3% for the three and nine months ended September 30, 2020, respectively, compared to 8.8% and 9.9% for the same respective periods in 2019 due to lower net premiums earned compared to the respective prior year periods.

The overall expense ratio (including commission and other acquisition expenses) for the three and nine months ended September 30, 2020 increased to 52.0% and 51.6% compared to 42.1% and 44.6% for the same respective periods in 2019 largely as a result of lower premium revenue compared to the respective prior year periods.

General and Administrative Expenses — General and administrative expenses decreased by $39.0 thousand or 2.4% for the three months ended March 31, 2021 compared to the same respective period in 2020.

The general and administrative expense ratio increased to 24.2% for the three months ended March 31, 2021 compared to 12.5% for the same respective period in 2020 largely due to lower net premiums earned in the current period.

The overall expense ratio (including commission and other acquisition expenses) for the three months ended March 31, 2021 increased to 81.9% compared to 51.0% for the same respective period in 2020 largely as a result of lower premium revenue in the current period.

AmTrust Reinsurance Segment

The AmTrust Reinsurance segment reported underwriting income of $4.5 million and $1.8 million during the three and nine months ended September 30, 2020, respectively, compared to an underwriting loss of $78.5 million and $160.1 million in the same respective periods in 2019.

The improvement in the underwriting results was due to improved loss development on prior years, which resulted in a sharply lower combined ratio on significantly lower earned premiums during the three and nine months ended September 30, 2020 compared to the respective periods in 2019.

The underwriting results and associated ratios for the AmTrust Reinsurance segment for the three and nine months ended September 30, 2020 and 2019 were as follows:

For the Three Months Ended September 30, For the Nine Months Ended September 30,

The AmTrust Reinsurance segment reported underwriting income of $1.8 million during the three months ended March 31, 2021 compared to an underwriting loss of $3.0 million in the same respective period in 2020.

The improvement in the underwriting results was due to impact of favorable prior year loss development during the three months ended March 31, 2021 compared to no loss development recognized in the same respective period in 2020.

The underwriting results and associated ratios for the AmTrust Reinsurance segment for the three months ended March 31, 2021 and 2020 were as follows:

For the Three Months Ended March 31,

($ in thousands) 2021 2020

10 unchanged sentences

General and administrative expenses

(630) (235) (1,941) (2,063)

Underwriting income (loss)

5 unchanged sentences

General and administrative expense ratio

4.8 % 0.3 % 4.7 % 0.6 %

Expense ratio

2 unchanged sentences

67.6 % 116.1 %

The combined ratio decreased 139.9 percentage points to 65.6% for the three months ended September 30, 2020 compared to 205.5% for the same period in 2019 partly due to the impact of favorable prior year loss development of $7.7 million or 59.5 percentage points during the third quarter of 2020 compared to the impact of adverse prior year development of $62.4 million or 83.8 percentage points for the same period in 2019.

Prior year favorable development in 2020 was primarily due to Workers Compensation partly offset by adverse development within Commercial Auto and General Liability.

The adverse loss development in Commercial Auto and General Liability for the three months ended September 30, 2020 was significantly more limited compared to the same period in 2019.

The adverse development in 2019 was primarily due to Commercial Auto and General Liability in accident years 2015 to 2018, partly offset by favorable development in Workers Compensation in accident years 2016 to 2018.

The combined ratio decreased 50.9 percentage points to 95.6% for the nine months ended September 30, 2020 compared to 146.5% for the same period in 2019 partly due to the impact of favorable prior year loss development of $8.1 million or 19.6 percentage points in the first nine months of 2020 compared to the impact of adverse prior year development of $97.6 million or 28.4 percentage points for the same period in 2019.

Prior year favorable development in 2020 was primarily due to Workers Compensation partly offset by adverse development within Commercial Auto and General Liability.

The adverse loss development in Commercial Auto and General Liability for the nine months ended September 30, 2020 was significantly more limited compared to the same period in 2019.

The adverse development in 2019 was primarily due to Commercial Auto and General Liability in accident years 2014 to 2018, partly offset by favorable development in Workers Compensation in accident years 2016 to 2018.

Premiums — There were negative gross and net premiums written for the three and nine months ended September 30, 2020 reflecting premium adjustments under the AmTrust Quota Share from April 1, 2020.

Furthermore, the termination of both the AmTrust Quota Share and the European Hospital Liability Quota Share as of January 1, 2019, led to no new business written under these contracts during 2020.

In 2019, the Partial Termination Amendment resulted in Maiden Reinsurance returning approximately $648.0 million in unearned premium to AII, or approximately $436.8 million net of applicable ceding commission and brokerage, which caused negative gross and net premiums written for the nine months ended September 30, 2019.

The tables below show net premiums written by category for the three and nine months ended September 30, 2020 and 2019:

For the Three Months Ended September 30, 2020 2019

($ in thousands) Total Total

Net Premiums Written

Small Commercial Business

$ (2,123) $ 8,050

Specialty Program

Specialty Risk and Extended Warranty

(3,303) 9,216

Total AmTrust Reinsurance

$ (5,635) $ 21,405

For the Nine Months Ended September 30, 2020 2019

The combined ratio decreased 48.5 percentage points to 67.6% for the three months ended March 31, 2021 compared to 116.1% for the same period in 2020.

This was driven by the impact of favorable prior year loss development of $5.6 million or 100.8 percentage points during the first quarter of 2021.

Prior year favorable development in 2021 was primarily due to Workers Compensation partly offset by adverse development within Hospital Liability.

Premiums — There were negative gross and net premiums written for the three months ended March 31, 2021 reflecting premium adjustments on Small Commercial Business policies in the AmTrust Quota Share.

Furthermore, the termination of the AmTrust Quota Share and the European Hospital Liability Quota Share as of January 1, 2019 resulted in no new business written under these contracts since 2018.

The table below shows net premiums written by category for the three months ended March 31, 2021 and 2020:

For the Three Months Ended March 31, 2021 2020

($ in thousands) Total Total

4 unchanged sentences

Specialty Risk and Extended Warranty

(1,849) (210,583)

Total AmTrust Reinsurance

$ (2,462) $ —

Net premiums earned decreased by $61.4 million or 82.6% and $302.3 million or 87.9% for the three and nine months ended September 30, 2020, respectively, compared to the same respective periods in 2019 due to the terminations of the AmTrust Quota Share and European Hospital Liability Quota Share as of January 1, 2019.

The negative net premiums earned on Small Commercial Business for the three and nine months ended September 30, 2020 was due to premium adjustments and earned premium returns under the recent commutation of certain home warranty business under the AmTrust Quota Share as of April 1, 2020.

The tables below detail net premiums earned by category for the three and nine months ended September 30, 2020 and 2019:

For the Three Months Ended September 30, 2020 2019 Change in

($ in thousands) Total % of Total Total % of Total $ %

Net Premiums Earned

Small Commercial Business

$ (1,921) (14.8) % $ 18,686 25.1 % $ (20,607) (110.3) %

Specialty Program

(190) (1.5) % 22,204 29.8 % (22,394) (100.9) %

Specialty Risk and Extended Warranty

15,093 116.3 % 33,516 45.1 % (18,423) (55.0) %

Total AmTrust Reinsurance

$ 12,982 100.0 % $ 74,406 100.0 % $ (61,424) (82.6) %

For the Nine Months Ended September 30, 2020 2019 Change in

Net premiums earned decreased by $13.2 million or 70.4% for the three months ended March 31, 2021 compared to the same respective period in 2020 due to termination of the AmTrust Quota Share and European Hospital Liability Quota Share as of January 1, 2019.

The negative premiums earned for the three months ended March 31, 2021 were due to premium adjustments on Small Commercial Business policies in the AmTrust Quota Share.

The table below details net premiums earned by category for the three months ended March 31, 2021 and 2020:

For the Three Months Ended March 31, 2021 2020 Change in

($ in thousands) Total % of Total Total % of Total $ %

8 unchanged sentences

$ 5,524 100.0 % $ 18,684 100.0 % $ (13,160) (70.4) %

Net Loss and LAE — Net loss and LAE decreased by $124.5 million or 98.1% and $352.6 million or 94.3% for the three and nine months ended September 30, 2020, respectively, compared to the same respective periods in 2019 due to significantly lower earned premiums as a result of the termination of both quota share agreements with AmTrust.

Net loss and LAE ratios decreased to 18.8% and 51.8% for the three and nine months ended September 30, 2020, respectively, compared to 170.6% and 108.8% for the same respective periods in 2019.

During the three months ended September 30, 2020, the net loss and LAE ratio decreased by 151.8 percentage points compared to the same period in 2019 primarily due to the following factors:

• the Partial Termination Amendment caused significant changes in the mix of business being earned in 2020 compared to 2019.

These changes resulted in a current year loss ratio which decreased relative to the same period in 2019 for the remaining in-force business;

• the impact of prior year loss development was favorable development of $7.7 million or 59.5 percentage points during the three months ended September 30, 2020 on the loss ratio, compared to the impact of adverse prior year loss development which was $62.4 million or 83.8 percentage points for the same period in 2019.

Prior year favorable development in 2020 was primarily due to Workers Compensation partly offset by adverse development within Commercial Auto and General Liability.

The adverse loss development in Commercial Auto and General Liability for the three months ended September 30, 2020 was significantly more limited compared to the same period in 2019.

Prior year adverse development in 2019 was due to favorable development in Commercial Auto and General Liability in accident years 2015 to 2018, partly offset by favorable development in Workers Compensation.

During the nine months ended September 30, 2020, the net loss and LAE ratio decreased by 57.0 percentage points compared to the same period in 2019 primarily due to the following factors:

• the Partial Termination Amendment caused significant changes in the mix of business being earned in 2020 compared to 2019.

These changes resulted in a current year loss ratio which decreased relative to the same period in 2019 for the remaining in-force business;

• the impact of prior year loss development was favorable development of $8.1 million or 19.6 percentage points during the nine months ended September 30, 2020 on the loss ratio, compared to the impact of adverse prior year loss development which was $97.6 million or 28.4 percentage points for the same period in 2019.

Prior year favorable development in 2020 was primarily due to Workers Compensation partly offset by adverse development within Commercial Auto and General Liability.

The adverse loss development in Commercial Auto and General Liability for the nine months ended September 30, 2020 was significantly more limited compared to the same period in 2019.

Prior year adverse development in 2019 was due to Commercial Auto and General Liability in accident years 2014 to 2018, partly offset by favorable development in Workers Compensation in accident years 2016 to 2018.

Commission and Other Acquisition Expenses — Commission and other acquisition expenses decreased by $20.3 million or 78.9% and $111.4 million or 87.3% for the three and nine months ended September 30, 2020, respectively, compared to the same respective periods in 2019 due to significantly lower earned premiums as a result of the terminations of both quota share agreements with AmTrust effective as of January 1, 2019.

The commission and other acquisition expense ratio increased to 42.0% and 39.1% for the three and nine months ended September 30, 2020, respectively, compared to 34.6% and 37.1% for the same respective periods in 2019.

General and Administrative Expenses — General and administrative expenses increased by $0.4 million or 168.1% and decreased by $0.1 million or 5.9% for the three and nine months ended September 30, 2020, respectively, compared to the same respective periods in 2019.

The general and administrative expense ratios increased to 4.8% and 4.7% for the three and nine months ended September 30, 2020, respectively, compared to 0.3% and 0.6% for the same respective periods in 2019 as a result of much lower earned premiums due to the termination of both quota share agreements with AmTrust as of January 1, 2019.

The overall expense ratio (including commission and other acquisition expenses) increased to 46.8% and 43.8% for the three and nine months ended September 30, 2020, respectively, compared to 34.9% and 37.7% for the same respective periods in 2019 primarily due to significantly lower earned premiums as discussed above.

Net Loss and LAE — Net loss and LAE decreased by $13.1 million or 93.3% for the three months ended March 31, 2021 compared to the same respective period in 2020 due to the impact of favorable prior year loss development of $5.6 million.

Net loss and LAE ratios decreased to 17.1% for the three months ended March 31, 2021 compared to 75.2% for the same respective period in 2020.

During the three months ended March 31, 2021, the net loss and LAE ratio decreased by 58.1 percentage points compared to the same period in 2020 primarily due to the impact of favorable prior year loss development of $5.6 million or 100.8 percentage points during the three months ended March 31, 2021 on the loss ratio.

There was no prior year loss development recognized for the same period in 2020.

Prior year favorable development in 2021 was primarily due to Workers Compensation partly offset by adverse development within Hospital Liability.

Commission and Other Acquisition Expenses — Commission and other acquisition expenses decreased by $4.8 million or 68.7% for the three months ended March 31, 2021 compared to the same respective period in 2020 due to lower net earned premiums as a result of terminating both quota share agreements with AmTrust effective as of January 1, 2019.

The commission and other acquisition expense ratio increased to 39.6% for the three months ended March 31, 2021 compared to 37.4% for the same respective period in 2020.

General and Administrative Expenses — General and administrative expenses decreased by $41.0 thousand or 6.4% for the three months ended March 31, 2021 compared to the same respective period in 2020.

The general and administrative expense ratios increased to 10.9% for the three months ended March 31, 2021 compared to 3.5% for the same respective period in 2020 as a result of lower earned premiums due to terminating both quota share agreements with AmTrust as of January 1, 2019.

The overall expense ratio (including commission and other acquisition expenses) increased to 50.5% for the three months ended March 31, 2021 compared to 40.9% for the same respective period in 2020 primarily due to significantly lower earned premiums as discussed above.

Liquidity and Capital Resources

2 unchanged sentences

The jurisdictions in which our operating subsidiaries are licensed to write business impose regulations requiring companies to maintain or meet statutory solvency and liquidity requirements and also place restrictions on the declaration and payment of dividends and other distributions.

As of September 30, 2020, the Company had investable assets of $2.4 billion compared to $2.8 billion as of December 31, 2019.

As of March 31, 2021, the Company had investable assets of $2.0 billion compared to $2.3 billion as of December 31, 2020.

Investable assets are the combined total of our investments, cash and cash equivalents (including restricted), loan to a related party and funds withheld receivable.

The decrease in investable assets is primarily the result of significant negative operating cash flows during nine months ended September 30, 2020, particularly as a result of our cessation of active reinsurance underwriting, including certain contract terminations that occurred in 2019 that require the disbursement of cash and investments to settle claim payments in 2020.

The regulatory and liquidity requirements of the Company's operating segments are discussed in "Management's Discussion and Analysis of Financial Condition and Results of Operations" section included under Item 7 of our Annual Report on Form 10- K for the year ended December 31, 2019, filed with the SEC on March 18, 2020.

As previously indicated, Maiden Reinsurance re-domesticated to Vermont on March 16, 2020.

The decrease in our investable assets is primarily the result of significant negative operating cash flows during three months ended March 31, 2021, particularly as a result of our cessation of active reinsurance underwriting combined with the disbursement of cash and investments to settle claim payments in 2021.

As previously indicated, Maiden Reinsurance re-domesticated from Bermuda to Vermont on March 16, 2020.

We continue to be actively engaged with the Vermont DFR regarding the formulation of Maiden Reinsurance's longer term business plan, including its investment policy, changes to which require prior regulatory approval as stipulated by Vermont law or the Vermont DFR for any active underwriting, capital management or other strategic initiatives.

Maiden Reinsurance has received all necessary approvals required to date by the Vermont DFR, including its investment policy.

The Company's investment portfolio may be adversely impacted by unfavorable market conditions caused by the COVID-19 pandemic and we and our insurance subsidiaries may need additional capital to maintain compliance with regulatory capital requirements and/or be required to post additional collateral under existing reinsurance arrangements, which could reduce our liquidity.

In addition, we may experience continued volatility in our results of operations which could negatively impact our

financial condition and create a reduction in the amount of available distribution or dividend capacity from our regulated reinsurance subsidiaries, which would also reduce liquidity.

Maiden Reinsurance has received all necessary approvals required to date by the Vermont DFR, including its investment policy which includes:

1) the expansion of approved asset classes for investment reflecting not only Maiden Reinsurance’s solvency position but the material reduction in required capital necessary to operate its business as discussed further in Item 7 - Management's Discussion and Analysis of Financial Condition and Results of Operations – Liquidity & Capital Resources – Cash and Investments ;

and 2) the purchase of affiliated securities as demonstrated in the recent preference share tender offers.

The Investment Policy, as approved and as may be amended, maintains our established investment management and governance practices.

We may experience continued volatility in our results of operations which could negatively impact our financial condition and create a reduction in the amount of available distribution or dividend capacity from our regulated reinsurance subsidiaries, which would also reduce liquidity.

Further, we and our insurance subsidiaries may need additional capital to maintain compliance with regulatory capital requirements and/or be required to post additional collateral under existing reinsurance arrangements, which could reduce our liquidity.

Finally, while we have had limited impacts from the effects of COVID-19 on our financial condition to date, the Company's investment portfolio could be adversely impacted by unfavorable market conditions caused by the pandemic should it continue longer than anticipated.

Operating, investing and financing cash flows

Our sources of funds historically have consisted of premium receipts net of commissions and brokerage, investment income, net proceeds from capital raising activities, and proceeds from sales, maturities, pay downs and redemption of investments.

Cash is currently used primarily to pay loss and LAE, ceded reinsurance premium, general and administrative expenses, and interest expense, with the remainder in excess of our operating requirements, made available to our investment managers for investment in accordance with our investment policy.

Our business has undergone significant changes in the past two years.

As previously noted, the Strategic Review resulted in a series of transactions that have materially reduced our balance sheet risk and have transformed our operations.

As a result of the transactions entered into from the Strategic Review, we are not engaged in any active underwriting of reinsurance business thus our net premiums written will continue to be materially lower in 2020 and investment income will become a significantly larger portion of our total revenues.

This has caused significant negative operating cash flows, particularly as we run off the AmTrust Reinsurance reserves as shown in the table below.

We expect this trend to continue going forward for the rest of 2020 and beyond.

Cash is currently used primarily to pay loss and LAE, ceded reinsurance premium, general and administrative expenses, and interest expense, with the remainder in excess of our operating requirements made available to our investment managers for investment in accordance with our investment policy as well as for capital management such as repurchasing our shares.

Our business has undergone significant changes since 2018.

As previously noted, the Strategic Review resulted in a series of transactions that materially reduced our balance sheet risk and transformed our operations.

As a result of the transactions entered into from the Strategic Review, we are not engaged in any active underwriting of reinsurance business thus our net premiums written will continue to be materially lower and investment related income will become a significantly larger portion of our total revenues.

This has caused significant negative operating cash flows as we run off the AmTrust Reinsurance reserves as shown in the cash flows table further below.

As noted in our Business Strategy, in November 2020, we formed GLS which will specialize in providing a full range of legacy services to small insurance entities, We believe the formation of GLS is highly complementary to our overall longer-term strategy and will not only enhance our profitability through both fee income and effective claims management services, but it will also increase our asset base through the addition of blocks of reserves or companies that can be successfully wound down.

While the development of the GLS platform over time should further enhance our ability to pursue the asset and capital management pillars of our business strategy, we still expect the trend of negative overall cash flows to continue to reduce our asset base going forward into 2021 and beyond.

We expect to use funds from cash and investment portfolios, collected premiums on reinsurance contracts in force or being run-off, investment income and proceeds from investment sales and redemptions to meet our expected claims payments and operational expenses.

Claim payments will be principally from the run-off of existing reserves for loss and loss adjustment expenses.

Claim payments will be principally from the run-off of existing reserves for loss and LAE.

A significant portion of those liabilities are collateralized and claim payments will be funded by using this collateral which should provide sufficient funding to fulfill those obligations.

We generally expect negative operating cash flows to be sufficiently offset by positive investing cash flows.

Overall, we continue to expect our cash flows to be sufficient to meet our cash requirements and to operate our business.

At September 30, 2020 and December 31, 2019, unrestricted cash and cash equivalents and unrestricted fixed maturity investments were $319.7 million and $435.0 million, respectively.

The Company’s management believes its current sources of liquidity are adequate to meet its cash requirements for the next twelve months.

The table below summarizes our operating, investing and financing cash flows for the nine months ended September 30, 2020 and 2019:

For the Nine Months Ended September 30, 2020 2019

The Company’s management believes its current sources of liquidity are adequate to meet its cash requirements for the next twelve months as we generally expect negative operating cash flows to be sufficiently offset by positive investing cash flows.

While we continue to expect our cash flows to be sufficient to meet our cash requirements and to operate our business, our ability to execute our asset and capital management initiatives are dependent on maintaining adequate levels of unrestricted liquidity and cash flows.

At March 31, 2021 and December 31, 2020, unrestricted cash and cash equivalents and unrestricted fixed maturity investments were $216.4 million and $269.2 million, respectively.

The decrease in these balances during 2021

was partly the result of the $97.4 million utilized for the 2021 Preference Share Repurchase and $8.0 million utilized for net purchases of other investments, as described further in the discussion on investing and financing cash flows below.

The table below summarizes our operating, investing and financing cash flows for the three months ended March 31, 2021 and 2020:

For the Three Months Ended March 31, 2021 2020

($ in thousands)

5 unchanged sentences

Effect of exchange rate changes on foreign currency cash

1,605 (1,269)

Total increase (decrease) in cash, restricted cash and cash equivalents

82,617 (264,176)

change in cash, restricted cash and cash equivalents of discontinued operations — (6,113)

Total change in cash, restricted cash and cash equivalents of continuing operations

$ 82,617 $ (258,063)

Total (decrease) increase in cash, restricted cash and cash equivalents $ (4,672) $ 70,684

Cash Flows used in Operating Activities

Cash flows used in operating activities for the nine months ended September 30, 2020 were $447.7 million compared to cash flows used in operating activities of $949.3 million for the nine months ended September 30, 2019, a decrease of $501.6 million.

Cash flows used in discontinued operations were $0.0 million for the nine months ended September 30, 2020 compared to $1.8 million in the nine months ended September 30, 2019.

Cash flows used in continuing operating activities were $447.7 million for the nine months ended September 30, 2020 compared to cash flows used in continuing operations of $947.4 million for the nine months ended September 30, 2019.

The operating cash flows used in continuing operations for the nine months ended September 30, 2020 and 2019 were primarily the result of the termination of the AmTrust Quota Share including both the Partial Termination Amendment and the Commutation and Release Agreement, and the termination of the European Hospital Liability Quota Share, which significantly decreased gross premiums written during both respective periods while claim payments have been principally from the run-off of existing reserves for loss and LAE.

Cash flows used in operating activities for the three months ended March 31, 2021 were $102.8 million compared to cash flows used in operating activities of $218.5 million for the three months ended March 31, 2020, a decrease of $115.7 million.

The operating cash flows used in operations for the three months ended March 31, 2021 and 2020 were primarily the result of the termination of the AmTrust Quota Share including both the Partial Termination Amendment and the Commutation and Release Agreement, and the termination of the European Hospital Liability Quota Share, which produced negligible gross premiums written while claim payments have been principally from the run-off of existing reserves for loss and LAE.

Cash Flows from Investing Activities

Cash flows from investing activities consist primarily of proceeds from the sales and maturities of investments and payments for investments acquired.

Net cash provided by investing activities was $528.7 million for the nine months ended September 30, 2020 compared to $686.4 million for the same period in 2019 primarily due to proceeds from the sale of fixed maturity investments which were made to settle claim payments during the nine months ended September 30, 2020.

Net cash provided by investing activities of $686.4 million for the same period in 2019 was primarily due to the sale of fixed maturity investments in the third quarter of 2019 which were made to settle the Commutation Payment of $312.8 million and retrocession premium of $445.0 million under the LPT/ADC Agreement.

Cash flows used in discontinued operations was $0.0 million for the nine months ended September 30, 2020 compared to cash flows used in discontinued operations of $6.1 million for the same period in 2019.

Cash flows provided by continuing operations was $528.7 million during the nine months ended September 30, 2020 compared to cash flows provided by

continuing operations of $692.5 million for the same period in 2019 as the proceeds from the sales, maturities and calls exceeded the purchases of fixed maturity securities by $572.8 million compared to an inflow of $695.8 million for the same period in 2019.

Net cash provided by investing activities was $199.2 million for the three months ended March 31, 2021 compared to $288.5 million for the same period in 2020 due to proceeds from the sale of fixed maturity investments which were made to settle claim payments during the three months ended March 31, 2021 and 2020.

For the three months ended March 31, 2021, the proceeds from the sales, maturities and calls exceeded the purchases of fixed maturity securities by $205.1 million compared to an inflow of $291.4 million for the same period in 2020.

Cash Flows from Financing Activities

Cash flows used in financing activities were $1.0 thousand for the nine months ended September 30, 2020 compared to $18.0 thousand for the same period in 2019 which represent repurchases of common shares to settle employee withholding in respect of tax obligations on the vesting of restricted shares and performance based shares.

No dividends on common or preference shares were paid during the nine months ended September 30, 2020 and 2019.

Cash flows used in financing activities were $99.9 million for the three months ended March 31, 2021 due to the repurchase of the Company's preference shares.

During March 2021, the Company paid $97.4 million for the repurchase of 6,614,493 preference shares pursuant to the 2021 Preference Share Repurchase as part of its recent capital management strategy.

No dividends on common or preference shares were paid during the three months ended March 31, 2021 and 2020.

Our Board of Directors have not declared any common or preference share dividends since the fourth quarter of 2018.

Restrictions, Collateral and Specific Requirements

The Company's restrictions, collateral and specific requirements are discussed in " Management's Discussion and Analysis of Financial Condition and Results of Operations " section included under Item 7 of our Annual Report on Form 10-K for the year ended December 31, 2019, filed with the SEC on March 18, 2020.

At September 30, 2020 and December 31, 2019, restricted cash and cash equivalents and fixed maturity investments used as collateral were $1.2 billion and $1.5 billion, respectively.

This collateral represents 78.4% and 77.6% of the fair value of our total fixed maturity investments and cash, restricted cash and cash equivalents at September 30, 2020 and December 31, 2019, respectively.

At March 31, 2021 and December 31, 2020, restricted cash and cash equivalents and fixed maturity investments used as collateral were $0.9 billion and $1.1 billion, respectively.

This collateral represents 80.5% and 80.0% of the fair value of our total fixed maturity investments and cash, restricted cash and cash equivalents at March 31, 2021 and December 31, 2020, respectively.

Cash and Investments

The investment of our funds has generally been designed to ensure safety of principal while generating current income.

Accordingly, the majority of our funds have been invested in liquid, investment-grade fixed income securities which are all designated as available-for-sale at September 30, 2020.

Please see " Notes to Condensed Consolidated Financial Statements (unaudited) Note 4.

Investments " included under Part I Item 1 " Financial Information" of this Form 10-Q.

As our insurance liabilities continue to run-off and the required capital to operate our business for regulatory purposes decreases, we may have the ability to consider additional asset classes to enhance the income and returns our investment portfolio produces.

We have and may continue to allocate a portion of our investment portfolio to other investments, including private equity and credit funds, fixed income funds, hedge funds, equity funds and other non-fixed income investments.

We categorize these investments as "Other Investments" on our condensed consolidated balance sheets.

Accordingly, the majority of our funds are invested in liquid, investment-grade fixed income securities which are all designated as available-for-sale at March 31, 2021.

As of March 31, 2021 and December 31, 2020, our cash and investments consisted of:

March 31, 2021 December 31, 2020

($ in thousands)

Fixed maturities, available-for-sale, at fair value $ 976,897 $ 1,213,411

Equity securities, at fair value 5,516 —

Equity method investments 40,183 39,886

Other investments 74,217 67,010

Total investments 1,096,813 1,320,307

Cash and cash equivalents 78,116 74,040

Restricted cash and cash equivalents 53,038 61,786

Total Investments and Cash (including cash equivalents) $ 1,227,967 $ 1,456,133

In addition to the discussion on Cash and Cash Equivalents and Fixed Maturities that follows herein, please see the " Notes to Condensed Consolidated Financial Statements (unaudited) Note 4.

Investments " included under Part I Item 1 " Financial Information" of this Form 10-Q for further discussion on our available-for-sale fixed income securities.

As our insurance liabilities continue to run-off and the required capital to operate our business for regulatory purposes decreases, we have modified Maiden Reinsurance’s investment policy (which has been approved by the Vermont DFR as noted) and have expanded the range of asset classes we invest in to enhance the income and returns our investment portfolio produces.

We categorize these investments as " Other Investments " and "Equity Method Investments" on our condensed consolidated balance sheets.

During 2020 and 2021, under this revised investment policy, we increased the amount of investments in these categories, and we expect to continue to increase the amounts invested therein.

Under our investment policy, investments included in these categories could include, but are not limited to, privately held investments, private equity, private credit lending funds, fixed-income funds, hedge funds, equity funds, real estate and other non-fixed-income investments.

For further details on these other investments, please see " Notes to Condensed Consolidated Financial Statements (unaudited) Note 4(b).

Other Investments" included under Part I Item 1 " Financial Information " of this Form 10-Q.

Our investment performance is subject to a variety of risks, including risks related to general economic conditions, market volatility, interest rate fluctuations, foreign exchange risk, liquidity risk and credit and default risk.

Interest rates are highly sensitive to many factors, including governmental monetary policies, domestic and international economic and political conditions and other factors beyond our control.

An increase in interest rates could result in significant losses, realized or unrealized, in the value of our investment portfolio.

A portion of portfolio consists of alternative investments that subject us to restrictions on redemption, which may limit our ability to withdraw funds for some period of time after the initial investment.

The values of, and returns on, such investments may also be more volatile.

We believe our other investments and equity method investments portfolio provides diversification against our fixed-income investments and an opportunity for improved risk-adjusted return, however, the returns of these investments may be more volatile and we may experience significant unrealized gains or losses in any particular quarter or year.

We may utilize and pay fees to various companies to provide investment advisory and/or management services related to these investments.

These fees, which would be predominantly based upon the amount of assets under management, would be included in net investment income.

We believe other investments and equity method investments would provide diversification against our fixed maturity investments and an opportunity for improved risk-adjusted returns;

however, the returns of other investments may be more volatile and we may experience significant unrealized gains or losses in any particular quarter or year.

The substantial majority of our current and future investments are held by Maiden Reinsurance, whose investment policy has been approved by the Vermont DFR.

The substantial majority of our current and planned future investments are held by Maiden Reinsurance, whose investment policy has been approved by the Vermont DFR.

We may utilize a portion of Maiden Reinsurance's unrestricted assets to purchase affiliated securities and, during the first quarter of 2021, we utilized $97.4 million in conjunction with the 2021 Preference Share Repurchase.

Maiden Reinsurance has received all necessary approvals for its investment policy.

During the nine months ended September 30, 2020, the yield on the 10-year U.S.

Treasury bond decreased by 123 basis points to 0.69%.

The 10-year U.S.

Treasury rate is the key risk-free determinant in the fair value of many of the securities in our portfolio.

Treasury yield curve experienced a material downward shift during the nine months ended September 30, 2020, reflecting significant global financial and economic volatility from the COVID-19 pandemic which spread during the first half of 2020.

The global nature of the pandemic resulted in an abrupt downturn in economic activity both globally and within the U.S., and financial markets experienced unprecedented volatility during this period.

Federal Reserve, along with central bankers globally, have implemented multiple rounds of rapid and aggressive monetary measures to provide liquidity to financial markets and to relieve imbalances that rapidly formed in those markets in the face of the pandemic and its economic and financial impacts.

Government policymakers in the U.S.

and globally have additionally implemented an ongoing series of unprecedented fiscal policy measures to provide immediate and near-term economic relief to affected populations.

The movement in the market values of our fixed maturity portfolio during the nine months ended September 30, 2020 generated net unrealized gains of $7.0 million, despite the ongoing COVID-19 pandemic which has caused widening credit spreads, a surging demand for liquidity and a slowdown to global economic activity.

Due in large part to the ongoing uncertainty caused by the COVID-19 pandemic in global financial markets during the nine months ended September 30, 2020, our investment portfolio experienced significant fluctuation in unrealized gains and losses (largely due to rapidly fluctuating credit spreads on fixed income investments), increased volatility, heightened credit risk, and declines in average yields on our fixed income investments.

Our investment portfolios may be adversely impacted by unfavorable market conditions caused by the COVID-19 pandemic, which could cause continued volatility in our results of operations and negatively impact our financial condition.

At September 30, 2020, we consider the levels of cash and cash equivalents we are holding to be within our targeted ranges.

During periods when interest rates experience greater volatility, we have periodically maintained more cash and cash equivalents in order to better assess current market conditions and opportunities within our defined risk appetite, and may do so in future periods.

To limit our exposure to unexpected interest rate increases which would reduce the value of our fixed income securities and reduce our shareholders' equity, we attempt to maintain the duration of our fixed maturity investment portfolio combined with our cash and cash equivalents, both restricted and unrestricted, within a reasonable range of the duration of our loss reserves.

At September 30, 2020 and December 31, 2019, these respective durations in years were as follows:

September 30, 2020 December 31, 2019

Fixed maturities and cash and cash equivalents

Reserve for loss and LAE (1)

(1) The duration regarding our reserve for loss and LAE at September 30, 2020 is gross of LPT/ADC Agreement reserves.

During the nine months ended September 30, 2020, the weighted average duration of our fixed maturity investment portfolio decreased by 0.7 years to 2.3 years and the duration for the reserve for loss and LAE increased by 0.2 years to 4.4 years.

The differential in duration between these assets and liabilities may fluctuate over time and in the case of fixed maturities, historically has been affected by factors such as market conditions, changes in asset mix and prepayment speeds in the case of both our agency mortgage-backed securities ("Agency MBS") and commercial mortgage-backed securities.

At September 30, 2020, the duration of our fixed maturity investment portfolio decreased compared to December 31, 2019 due to sales of fixed maturity investments primarily as a result of settling claim payments with AmTrust.

At September 30, 2020, the duration of our loss reserves net of the LPT/ADC Agreement was in line with the duration of our fixed maturity investment portfolio.

The average yield and average duration of our fixed maturities, by asset class, and our cash and cash equivalents (restricted and unrestricted) are as follows at September 30, 2020 and December 31, 2019, respectively:

September 30, 2020 Original or Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Average yield (1)

Cash & Cash Equivalents

At March 31, 2021, we consider the levels of cash and cash equivalents we are holding to be within our targeted ranges.

During periods when interest rates experience greater volatility, we have periodically maintained more cash and equivalents to better assess current market conditions and opportunities within our defined risk appetite, and may do so in future periods.

Fixed Maturity Investments

The average yield and average duration of our fixed maturities, by asset class, and our cash and cash equivalents (restricted and unrestricted) are as follows at March 31, 2021 and December 31, 2020, respectively:

March 31, 2021 Original or Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Average yield (1)

Average duration (2)

4 unchanged sentences

184,531 6,514 (122) 190,923 2.8 % 3.2

government and supranational bonds

8,649 605 (32) 9,222 1.1 % 6.4

government bonds 7,256 605 (16) 7,845 1.0 % 6.3

Asset-backed securities

2 unchanged sentences

503,938 23,532 (6,115) 521,355 2.1 % 3.2

1,258,915 41,384 (12,332) 1,287,967 2.4 % 2.7

Total fixed maturities 951,186 32,088 (6,377) 976,897 2.1 % 2.6

Cash and cash equivalents

8 unchanged sentences

272,124 9,439 (126) 281,437 2.5 % 1.9

government and supranational bonds

11,796 294 (91) 11,999 1.2 % 4.6

government bonds 8,641 1,067 — 9,708 1.1 % 6.2

Asset-backed securities

2 unchanged sentences

604,463 40,904 (3,035) 642,332 2.3 % 3.1

Municipal bonds

4,091 55 — 4,146 4.6 % 1.4

1,813,426 39,731 (17,639) 1,835,518 3.0 % 3.2

Total fixed maturities 1,163,923 53,055 (3,567) 1,213,411 2.2 % 2.3

Cash and cash equivalents

3 unchanged sentences

(2) Average duration in years.

At September 30, 2020 and December 31, 2019, 100.0% of the Company’s U.S.

During the three months ended March 31, 2021, the yield on the 10-year U.S.

Treasury bond increased by 81 basis points to 1.74%.

The 10-year U.S.

Treasury rate is the key risk-free determinant in the fair value of many of the fixed maturity securities in our portfolio.

Treasury yield curve experienced a material upward shift during the three months ended March 31, 2021, reflecting concerns about potential inflation emanating from the combination of:

1) growing confidence in the U.S.

economic outlook as the economic effects of the COVID-19 pandemic continue to abate;

2) enactment of additional significant fiscal stimulus legislation in the U.S.;

and 3) continued accommodative monetary policy pursued by central banks globally.

The movement in the market values of our fixed maturity portfolio during the three months ended March 31, 2021 generated net unrealized losses of $23.8 million.

Interest rate risk is the price sensitivity of a security to changes in interest rates.

Credit spread risk is the price sensitivity of a security to changes in credit spreads.

As noted, the fair value of our fixed maturity investments will fluctuate with changes in interest rates and credit spreads.

We attempt to maintain adequate liquidity in our fixed maturity investments portfolio with a strategy designed to emphasize the preservation of our invested assets and provide sufficient liquidity for the prompt payment of claims and contract liabilities.

Because we collateralize a significant portion of our insurance liabilities, unanticipated or large increases in interest rates could require us to utilize significant amounts of unrestricted cash and fixed maturity securities to provide additional collateral, which could impact our asset and capital management strategy described herein.

We also monitor the duration and structure of our investment portfolio as discussed below.

As of March 31, 2021, the aggregate hypothetical change in fair value from an immediate 100 basis points increase in interest rates, assuming credit spreads remain constant, in our fixed maturity investments portfolio would decrease the fair value of that portfolio by $33.3 million.

Actual shifts in interest rates may not change by the same magnitude across the maturity spectrum or on an individual security and, as a result, the impact on the fair value of our fixed maturity securities may be materially different from the resulting change in value described above.

At March 31, 2021 and December 31, 2020, these respective durations in years were as follows:

March 31, 2021 December 31, 2020

Fixed maturities and cash and cash equivalents

Reserve for loss and LAE (1)

(1) The duration regarding our reserve for loss and LAE at March 31, 2021 is gross of LPT/ADC Agreement reserves.

On a net basis, the duration of our reserve for loss and LAE is 0.9 years at March 31, 2021 (December 31, 2020 - 0.9 years).

During the three months ended March 31, 2021, the weighted average duration of our fixed maturity investment portfolio increased by 0.2 years to 2.3 years while the duration for the reserve for loss and LAE remains unchanged at 3.9 years.

At March 31, 2021, the duration of our fixed maturity investment portfolio increased slightly compared to December 31, 2020.

At March 31, 2021, the duration of our loss reserves net of the LPT/ADC Agreement was in line with the duration of our fixed maturity investment portfolio.

At March 31, 2021 and December 31, 2020, 100.0% of the Company’s U.S.

agency bond holdings are mortgage-backed.

Additional details on the Agency MBS at September 30, 2020 and December 31, 2019 were as follows:

September 30, 2020 December 31, 2019

Additional details on the Agency MBS holdings at March 31, 2021 and December 31, 2020 were as follows:

March 31, 2021 December 31, 2020

($ in thousands) Fair Value % of Total Fair Value % of Total

agency bonds - mortgage-backed

Residential mortgage-backed ("RMBS")

GNMA – fixed rate

7 unchanged sentences

$ 190,923 100.0 % $ 281,437 100.0 %

Our Agency MBS portfolio is 27.2% of our fixed maturity investments at September 30, 2020.

Given the relative size of this portfolio to our total investments, if faster prepayment patterns were to occur over an extended period of time, this could potentially limit the growth in our investment income in certain circumstances or reduce the total amount of investment income we earn.

At September 30, 2020 and December 31, 2019, 96.6% and 99.7%, respectively, of our fixed maturity investments consisted of investment grade securities.

Agency MBS bonds comprise 19.5% of our fixed maturity investments at March 31, 2021.

Given their relative size to our total investments, if faster prepayment patterns were to occur over an extended period of time, this could potentially limit the growth in our investment income in certain circumstances or reduce the total amount of investment income we earn.

At March 31, 2021 and December 31, 2020, 96.2% and 96.1%, respectively, of our fixed maturity investments consisted of investment grade securities.

We define a security as being below investment grade if it has an S&P credit rating of BB+ or equivalent, or less.

1 unchanged sentence

Investments " for additional information on the credit rating of our fixed income portfolio.

The security holdings by sector and financial strength rating of our corporate bond holdings at September 30, 2020 and December 31, 2019 were as follows:

September 30, 2020 AAA, AA+, AA, AA- A+, A, A- BBB+, BBB, BBB- BB+ or lower Fair Value % of Corporate bonds portfolio

The security holdings by sector and financial strength rating of our corporate bond holdings at March 31, 2021 and December 31, 2020 were as follows:

March 31, 2021 AAA, AA+, AA, AA- A+, A, A- BBB+, BBB, BBB- BB+ or lower Fair Value % of Corporate bonds portfolio

Corporate bonds

26 unchanged sentences

(1) Ratings as assigned by S&P, or equivalent

At September 30, 2020, the Company’s ten largest corporate holdings, 50.9% of which are U.S.

At March 31, 2021, the Company’s ten largest corporate holdings, 46.3% of which are U.S.

dollar denominated, 38.3% of which are in the Consumer Sector and 39.6% of which are in the Financial Institutions sector, at fair value and as a percentage of all fixed income securities were as follows:

September 30, 2020 Fair Value % of Holdings Rating (1)

March 31, 2021 Fair Value % of Holdings Rating (1)

($ in thousands)

Electricite de France, 4.625%, Due 9/11/2024 $ 17,573 1.8 % A-

UBS Group Funding (Jersey) Ltd, 2.65% Due 2/1/2022 17,487 1.4 % A-

Abbvie Inc., 3.80%, Due 3/15/2025 16,633 1.3 % BBB

Brookfield Asset Management Inc., 4.00% Due 1/15/2025 13,106 1.3 % A-

Nordea Bank ABP, 0.875% Due 6/26/2023 13,092 1.3 % A

Anheuser-Busch INBEV NV, 2.875% Due 9/25/2024 13,063 1.0 % BBB+

Bayer US Finance LLC, 3.375% Due 10/8/2024 13,054 1.0 % BBB+

Deutsche Bank AG, 1.25%, Due 9/8/2021 12,979 1.3 % BBB-

Bayer US Finance LLC, 3.375% Due 10/8/2024 12,925 1.3 % BBB+

Anheuser-Busch INBEV NV, 2.875% Due 9/25/2024 12,921 1.3 % BBB+

Carlsberg Breweries A/S, 2.5%, Due 5/28/2024 12,625 1.3 % BBB

Deutsche Bank AG (NY Branch), 3.7%, Due 5/30/2024 11,762 1.2 % BBB-

Total Capital International SA, 3.75%, Due 4/10/2024 10,962 1.1 % A+

Thompson Reuters Corp, 4.3% Due 11/23/23 10,796 1.1 % BBB

$ 128,741 13.2 %

(1) Ratings as assigned by S&P, or equivalent

At September 30, 2020 and December 31, 2019, respectively, we hold the following non-U.S.

At March 31, 2021 and December 31, 2020, respectively, we hold the following non-U.S.

dollar denominated securities:

September 30, 2020 December 31, 2019

March 31, 2021 December 31, 2020

($ in thousands) Fair Value % of Total Fair Value % of Total

dollar denominated corporate bonds $ 331,852 97.7 % $ 349,231 97.3 %

government and supranational bonds 9,222 2.6 % 11,999 3.7 %

government bonds 7,845 2.3 % 9,708 2.7 %

Total non-U.S.

1 unchanged sentence

$ 339,697 100.0 % $ 358,939 100.0 %

At September 30, 2020 and December 31, 2019, respectively, these non-U.S.

At March 31, 2021 and December 31, 2020, respectively, these non-U.S.

securities are invested in the following currencies:

September 30, 2020 December 31, 2019

March 31, 2021 December 31, 2020

($ in thousands) Fair Value % of Total Fair Value % of Total

6 unchanged sentences

$ 339,697 100.0 % $ 358,939 100.0 %

The net increase in non-U.S.

denominated fixed maturities is primarily due to the depreciation of Euro denominated corporate bonds during the nine months ended September 30, 2020.

At September 30, 2020 and December 31, 2019, all of the Company's non-U.S.

government and supranational issuers have a rating of A or higher by S&P.

The net decrease in non-U.S.

denominated fixed maturities is primarily due to the relative depreciation of Euro denominated corporate bonds during the three months ended March 31, 2021.

At March 31, 2021 and December 31, 2020, all of the Company's non-U.S.

government issuers have a rating of A or higher by S&P.

For our non-U.S.

dollar denominated corporate bonds, the following table summarizes the composition of the fair value of our fixed maturity investments at the dates indicated by ratings:

September 30, 2020 December 31, 2019

March 31, 2021 December 31, 2020

($ in thousands) Fair Value % of Total Fair Value % of Total

8 unchanged sentences

The Company does not employ any credit default protection against any of the fixed maturities held in non-U.S.

denominated currencies at September 30, 2020 and December 31, 2019, respectively.

denominated currencies at March 31, 2021 and December 31, 2020, respectively.

Other Investments, Equity Method Investments and Equity Securities

Our alternative investments are categorized as other investments, equity method investments, and equity securities.

These include private equity and hedge funds investments, investments in limited partnerships, as well as investments in direct lending entities and investments in technology-oriented insurance related businesses known as insurtechs.

Our allocation to alternative investments increased to 9.8% of our total cash and investments as of March 31, 2021 compared to 7.3% as of December 31, 2020;

and increased to 28.1% of our total shareholders' equity as of March 31, 2021 compared to 20.3% as of December 31, 2020.

For further details on these other investments, please see " Notes to Condensed Consolidated Financial Statements:

Note 4 - Investments" included under Part I Item 1.

"Financial Information" of this Report on Form 10-Q.

Other Balance Sheet Changes

The following table summarizes the Company's other material balance sheet changes at September 30, 2020 and December 31, 2019:

($ in thousands) September 30, 2020 December 31, 2019 Change Change %

The following table summarizes our other material balance sheet changes at March 31, 2021 and December 31, 2020:

($ in thousands) March 31, 2021 December 31, 2020 Change Change %

Reinsurance recoverable on unpaid losses

2 unchanged sentences

46,852 51,903 (5,051) (9.7) %

Funds withheld receivable

652,855 684,441 (31,586) (4.6) %

Other assets 18,462 8,051 10,411 129.3 %

Reserve for loss and LAE

7 unchanged sentences

The Company's deferred commission and other acquisition expenses decreased by 9.7% and unearned premiums decreased by 10.7% primarily due to the Partial Termination Amendment with AmTrust on a cut-off basis and the termination of the remaining business under both quota share contracts with AmTrust which are now in run-off with no new business written beginning January 1, 2019.

Funds withheld receivable decreased by 4.6% primarily due to lower funds withheld to be utilized as collateral for the European Hospital Liability Quota Share.

Accrued expenses and other liabilities increased by 38.8% as at September 30, 2020 compared to December 31, 2019 due to increases in reinsurance balances payable, particularly claims, to AmTrust.

The Company's reserve for loss and LAE decreased by 19.1% primarily due to the recent commutation of workers' compensation reserves during 2019 in the AmTrust Reinsurance segment.

The deferred gain on retroactive reinsurance decreased by 29.2%.

The decrease in the unamortized deferred gain on retroactive reinsurance for the nine months ended September 30, 2020 is attributable to the following:

1) $9.3 million in loss and loss adjustment expenses recognized as favorable loss development in the Company’s GAAP income statement that are subject to the LPT/ADC Agreement;

and 2) $23.7 million related to a reduction in estimated ultimate losses for certain workers’ compensation losses previously commuted by the Company to AmTrust which are subject to specific terms and conditions pursuant to the LPT/ADC Agreement.

This also impacted the reinsurance recoverable on unpaid losses which decreased by 4.1% as at September 30, 2020 compared to December 31, 2019.

Accrued expenses and other liabilities decreased by 22.2% as at March 31, 2021 compared to December 31, 2020 due to payment of reinsurance balances payable as a result of claims incurred under the run-off of AmTrust reinsurance contracts.

The Company's reserve for loss and LAE decreased by 5.7% primarily due to the payment of prior year loss claims as well as favorable loss development recognized for the AmTrust Reinsurance segment.

The decrease in the deferred gain on retroactive reinsurance for the three months ended March 31, 2021 by 13.1% is attributable to $9.8 million in loss and loss adjustment expenses recognized as favorable loss development in the Company’s GAAP income statement that are covered by the LPT/ADC Agreement.

This also impacted the reinsurance recoverable on unpaid losses which decreased by $11.9 million or 2.0% as at March 31, 2021 compared to December 31, 2020.

Other assets increased by 129.3% as at March 31, 2021 compared to December 31, 2020 due to the receivable for securities sold at the end of the first quarter of 2021.

Capital Resources

Capital resources consist of funds deployed in support of our operations.

In the nine months ended September 30, 2020, our total capital resources increased by $30.4 million, or 3.9% compared to December 31, 2019 due to net income attributable to common shareholders partly offset by unrealized gains on our investment portfolio.The following table shows the movement in total capital resources at September 30, 2020 and December 31, 2019:

($ in thousands) September 30, 2020 December 31, 2019 Change Change %

In the three months ended March 31, 2021, our total capital resources decreased by $101.2 million, or 12.8% compared to December 31, 2020 due to unrealized losses on our fixed maturity investment portfolio and repurchases of preference shares partially offset by net income attributable to common shareholders.

The following table shows the movement in total capital resources at March 31, 2021 and December 31, 2020:

($ in thousands) March 31, 2021 December 31, 2020 Change Change %

Preference shares

8 unchanged sentences

$ 689,111 $ 790,316 $ (101,205) (12.8) %

The major factors contributing to the net increase in capital resources were as follows:

Shareholders' equity

Total shareholders' equity at September 30, 2020 increased by $30.4 million, or 6.0% compared to December 31, 2019 due to the following factors:

• net income attributable to Maiden of $32.2 million for the nine months ended September 30, 2020;

• net increase in share based transactions of $2.0 million;

partly offset by

The major factors contributing to the net decrease in total capital resources were primarily due to total shareholders' equity at March 31, 2021 which decreased by $101.2 million, or 19.2% compared to December 31, 2020 due to the following factors:

• net decrease of $97.4 million from the 2021 Preference Share Repurchase composed of a decline in preference share capital of $165.4 million partly offset by:

(1) a gain on repurchase of preference shares of $62.5 million for the three months ended March 31, 2021 which increased retained earnings;

and (2) a net increase in additional paid-in capital of $5.5 million relating to proportionate share in issuance costs of preference shares repurchased, which was previously recognized as a reduction in additional paid-in capital;

• net decrease in AOCI of $14.6 million which arose due to:

(1) an increase in net unrealized gains on investment of $6.9 million resulting from the net increase in the fair value of our investment portfolio relating to market price movements due to widening credit spreads and unfavorable economic conditions during the nine months ended September 30, 2020;

and (2) a decrease in cumulative translation adjustments of $10.8 million due to the effect of the appreciation of

the euro relative to the original currencies on our non-U.S.

dollar net liabilities (excluding non-U.S.

dollar denominated AFS fixed maturities).

On February 21, 2017, the Company's Board of Directors approved the repurchase of up to $100.0 million of the Company's common shares from time to time at market prices.

During the nine months ended September 30, 2020, the Company did not repurchase any common shares under its share repurchase authorization, as it is precluded from repurchasing its common shares due to its failure to pay dividends on its preference shares.

Until such time as dividends on preference shares are paid, the Company will not be able to repurchase or pay dividends on its common shares.

At September 30, 2020, the Company has a remaining authorization of $74.2 million for share repurchases.

(1) net unrealized losses on investment of $24.7 million resulting from the net decrease in the fair value of our investment portfolio relating to market price movements due to rising interest rates during the three months ended March 31, 2021;

less (2) an increase in cumulative translation adjustments of $10.1 million due to the strengthening of the U.S.

dollar on the remeasurement of net insurance-related liabilities denominated in euro during the three months ended March 31, 2021;

partly offset by:

• net income attributable to Maiden of $9.3 million for the three months ended March 31, 2021;

• net increase due to share-based compensation of $1.5 million.

Please refer to " Notes to Consolidated Financial Statements Note 13.

1 unchanged sentence

" Financial Statements and Supplementary Data" of our Annual Report on Form 10-K for a discussion of the equity instruments issued by the Company as at December 31, 2020.

On October 25, 2019, the Company transferred the listing of its common shares from the NASDAQ Global Select Market to the NASDAQ Capital Market.

The NASDAQ Capital Market is a continuous trading market that operates in substantially the same manner as the NASDAQ Global Select Market and listed companies must meet certain financial requirements and comply with the NASDAQ Stock Market LLC’s (“NASDAQ”) corporate governance requirements.

The Company’s common shares continue to trade under the symbol “MHLD”.

On April 17, 2020, the Company received a letter from NASDAQ stating that the Company had not regained compliance during the compliance period and that the Company’s securities would be delisted from the NASDAQ Capital Market by the opening of business on April 28, 2020 unless the Company requests an appeal of NASDAQ’s determination to a Hearings Panel.

On April 24, 2020, the Company filed a Hearing Request Form to appeal NADSAQ’s determination with the Hearings Panel, which stayed the de-listing until a decision is rendered subsequent to the appeal hearing.

On June 2, 2020, the Company issued a press release announcing it has regained compliance with NADSAQ’s mimimum bid price and all applicable listing requirements for continued listing, and the appeal hearing was canceled.

Accordingly, the Company's common shares continue to be listed on the NASDAQ Capital Market.

Book value and diluted book value per common share at September 30, 2020 and December 31, 2019 were computed as follows:

September 30, 2020 December 31, 2019

($ in thousands except share and per share data)

Book value and diluted book value per common share at March 31, 2021 and December 31, 2020 were computed as follows:

($ in thousands except share and per share data) March 31, 2021 December 31, 2020

Ending common shareholders’ equity

$ 197,663 $ 133,506

Proceeds from assumed conversion of dilutive options

Numerator for diluted book value per common share calculation

9 unchanged sentences

Diluted book value per common share

At September 30, 2020, book value per common share increased by 68.6% and diluted book value per common share increased by 70.0%, compared to December 31, 2019.

This was primarily due to our net income attributable to common shareholders of $32.2 million during the nine months ended September 30, 2020, partly offset by the net decrease in AOCI of $3.9 million for the nine months ended September 30, 2020.

Please see the section named " Liquidity and Capital Resources - Investments" above for further information on the change in fair value of our fixed maturity investment portfolio.

There were no changes in the Company’s Senior Notes at September 30, 2020 compared to December 31, 2019 and the Company did not enter into any short-term borrowing arrangements during the nine months ended September 30, 2020.

During the three months ended March 31, 2021, book value per common share increased by 45.9% to $2.29 and diluted book value per common share increased by 47.1% to $2.28, compared to December 31, 2020.

This was primarily due to the gain of $62.5 million on the 2021 Preference Share Repurchase which increased book value by $0.73 per common share.

Book value also increased due to net income of $9.3 million during the three months ended March 31, 2021, partially offset by a net decrease in AOCI of $14.6 million for the three months ended March 31, 2021.

Common Shares

On February 21, 2017, the Company's Board of Directors approved the repurchase of up to $100.0 million of the Company's common shares from time to time at market prices.

During the three months ended March 31, 2021, the Company did not repurchase any common shares under its share repurchase authorization as it is precluded from repurchasing its common shares due to its failure to pay dividends on its preference shares.

Until such time as dividends on preference shares are paid, the Company will not be able to repurchase or pay dividends on its common shares.

At March 31, 2021, the Company had a remaining authorization of $74.2 million for share repurchases.

On October 25, 2019, the Company transferred the listing of its common shares from the NASDAQ Global Select Market to the NASDAQ Capital Market.

The Company’s common shares trade under the symbol “MHLD”.

On April 24, 2020, the Company filed a Hearing Request Form to appeal NADSAQ’s determination with the Hearings Panel.

On June 2, 2020, the Company issued a press release announcing it had regained compliance with NADSAQ’s mimimum bid price and all applicable listing requirements for continued listing, and the appeal hearing was canceled.

Accordingly, the Company's common shares continue to be listed on the NASDAQ Capital Market.

Preference Shares

As part of the capital management pillar of our strategy, pursuant to the cash tender offer on December 24, 2020, Maiden Reinsurance accepted for purchase (i) 545,218 shares of the Company's 8.25% Non-Cumulative Preference Shares Series A, (ii) 1,203,466 shares of the Company's 7.125% Non-Cumulative Preference Shares Series C and (iii) 1,078,911 shares of the Company's 6.7% Non-Cumulative Preference Shares Series D (collectively referred to as the "2020 Tender Offer").

The acquisition by Maiden Reinsurance of the preference shares pursuant to the tender offer was made in compliance with Maiden Reinsurance's investment policy previously approved b y the Vermont DFR.

The principal purpose of the 2020 Tender Offer was to adjust our capital structure to reflect current operations and the amount of capital required to operate Maiden Reinsurance.

The Board has not declared or paid a dividend on the preference shares since the fourth quarter of 2018 and there can be no assurance that it will declare and pay dividends on the preference shares in the future.

The preference shares are perpetual and there is no fixed date on which we are required to redeem or otherwise repurchase them.

Maiden Reinsurance used unrestricted cash of $29.7 million to repurchase the preference shares pursuant to the 2020 Tender Offer.

On March 3, 2021, the Company's Board approved the repurchase, including the repurchase by Maiden Reinsurance within its investment guidelines, of up to $100.0 million of the Company's preference shares.

Please refer to "Notes to Consolidated Financial Statements - Note 6 — Shareholders' Equity" under Part 1 Item 1 "Financial Information" of this Quarterly Report on Form 10-Q for further information on our preference shares.

During March 2021, Maiden Reinsurance accepted for purchase primarily via private negotiation with certain security holders, (i) 2,561,636 shares of the Company's 8.25% Non-Cumulative Preference Shares Series A at an average price of $14.88 per share, (ii) 2,028,961 shares of the Company's 7.125% Non-Cumulative Preference Shares Series C at an average price of $14.65 per share, and (iii) 2,023,896 shares o f the Company's 6.7% Non-Cumulative Preference Shares Series D at an average price of $14.60 per share for a total amount of $97.4 million.

The acquisition by Maiden Reinsurance of these preference shares was made in compliance with the Company's investment guidelines previously approved by the Vermont DFR.

These purchases have resulted in a gain on purchase of $62.5 million in the first quarter of 2021.

As of March 31, 2021 , the Company had a remaining authorization of $2.6 million for preference share repurchases.

On May 6, 2021, the Company's Board of Directors approved the additional repurchase, including the repurchase by Maiden Reinsurance in accordance with its investment guidelines (as may be amended), of up to $50.0 million the Company's preference shares from time to time at market prices in open market purchases or as may be privately negotiated.

There were no changes in the Company’s Senior Notes at March 31, 2021 compared to December 31, 2020 and the Company did not enter into any short-term borrowing arrangements during the three months ended March 31, 2021.

Please refer to " Notes to Condensed Consolidated Financial Statements (unaudited) Note 7.

Long Term Debt " included under Part I Item 1 " Financial Information" of this Form 10-Q for a discussion of the Company’s Senior Notes.

The ratio of Debt to Total Capital Resources at September 30, 2020 and December 31, 2019 was computed as follows:

September 30, 2020 December 31, 2019

($ in thousands)

The ratio of Debt to Total Capital Resources at March 31, 2021 and December 31, 2020 was computed as follows:

($ in thousands) March 31, 2021 December 31, 2020

Senior notes - principal amount

6 unchanged sentences

38.1 % 33.2 %

Preference Shares

On November 13, 2020, the Company announced that commencing November 16, 2020, Maiden Reinsurance was offering to purchase for cash, upon the terms and subject to the conditions set forth in its Offer to Purchase ("Purchase Offer") and accompanying Letter of Transmittal, up to $100.0 million of its 8.25% Non-Cumulative Preference Shares Series A, 7.125% Non-Cumulative Preference Shares Series C and 6.7% Non-Cumulative Preference Shares Series D (the "Preference Securities").

The acquisition by Maiden Reinsurance of the Preference Securities pursuant to the Purchase Offer is being made in compliance with Maiden Reinsurance's investment policy previously approved by the Vermont DFR.

The principal purpose of the Purchase Offer is to adjust the Company's and Maiden Reinsurance’s capital structure to reflect its current operations and the amount of capital that is required to operate.

The Company's Board of Directors has not declared or paid a dividend on the Preference Securities since the fourth quarter of 2018 and there can be no assurance that it will declare and pay dividends on the Preference Securities in the future.

The Preference Securities are perpetual and there is no fixed date on which we are required to redeem or otherwise repurchase them.

Further, given the perpetual form of capital the Preference Securities represent, there can be no assurance that the Company or Maiden Reinsurance will make additional offers in the future to purchase the Preference Securities.

The Company expects to use cash on hand to pay the consideration payable by it pursuant to the Purchase Offer and the fees and expenses incurred by it in connection therewith.

The Offer is neither conditioned upon any minimum number of Securities being tendered, nor subject to any financing condition.

The Company or Maiden Reinsurance reserves the right, but is not obligated to, increase the Maximum Aggregate Purchase Amount in its sole and absolute discretion.

The Purchase Offer will expire on December 15, 2020 at 11:59 p.m., New York City time, unless the Company or Maiden Reinsurance extends it (such date and time, as the same may be extended, the "Expiration Date").

If the aggregate Offer Price of the Preference Securities that are validly tendered and not properly withdrawn at the Expiration Time (the "Total Consideration Amount") exceeds the Maximum Aggregate Purchase Amount, Maiden Reinsurance will accept for purchase that number of Securities that does not result in the Total Consideration Amount exceeding the Maximum Aggregate Purchase Amount.

In that event, the Securities will be subject to proration, as will be described in the Purchase Offer.

Non-GAAP Measures

2 unchanged sentences

The calculation, reconciliation to nearest GAAP measure and discussion of relevant non-GAAP measures used by management are as follows:

Non-GAAP operating loss was $2.3 million for the three months ended September 30, 2020, compared to non-GAAP operating earnings of $39.5 million for the same period in 2019.

The Company's non-GAAP operating results included a non-GAAP underwriting loss of $4.4 million for the three months ended September 30, 2020, compared to underwriting income of $24.3 million for the same period in 2019, which was primarily the result of underwriting results not covered by the LPT/ADC Agreement, specifically the run-off of the AmTrust Quota Share with losses occurring after December 31, 2018 (including the additional ceding commission paid under the Partial Termination Amendment) as well as claims related to the European Hospital Liability Quota Share.

Non-GAAP operating earnings were $2.0 million for the nine months ended September 30, 2020, compared to a non-GAAP operating loss of $9.4 million for the same period in 2019.

The Company's non-GAAP operating results included a non-GAAP underwriting loss of $9.6 million for the nine months ended September 30, 2020, compared to a non-GAAP underwriting loss of $57.5 million for the same period in 2019, which was primarily the result of underwriting results in the AmTrust segment not covered by the LPT/ADC Agreement, specifically the run-off of the AmTrust Quota Share with losses occurring after December 31, 2018 (including the additional ceding commission paid under the Partial Termination Amendment) as well as claims related to the European Hospital Liability Quota Share.

The significant improvement in non-GAAP underwriting losses for the nine months ended September 30, 2020 as compared to the same period 2019 was also assisted by a $9.8 million decline in other general and administrative expenses offset by a $31.4 million decrease in net investment income.

Non-GAAP operating earnings (loss) and Non-GAAP diluted operating earnings (loss) per share attributable to common shareholders

Non-GAAP operating earnings (loss) and non-GAAP diluted operating earnings (loss) per share attributable to common shareholders can be reconciled to the nearest U.S.

Non-GAAP operating earnings were $47.3 million for the three months ended March 31, 2021 compared to non-GAAP operating earnings of $3.1 million for the same period in 2020.

The Company's non-GAAP operating results included a non-GAAP underwriting loss of $8.3 million for the three months ended March 31, 2021 compared to an underwriting loss of $3.7 million for the same period in 2020, due to underwriting results not covered by the LPT/ADC Agreement, specifically the run-off of the AmTrust Quota Share with losses occurring after December 31, 2018 (including the additional ceding commission paid under the Partial Termination Amendment) as well as claims related to the European Hospital Liability Quota Share.

Non-GAAP operating earnings and Non-GAAP diluted operating earnings per share attributable to common shareholders

Non-GAAP operating earnings and non-GAAP diluted operating earnings per share attributable to common shareholders can be reconciled to the nearest U.S.

GAAP financial measure as follows:

For the Three Months Ended September 30, 2020 2019

($ in thousands except per share data)

Net income (loss)

$ 2,162 $ (58,327)

Add (subtract):

Net realized gains on investment (4,133) (12,700)

Total other-than-temporary impairment losses 962 165

Foreign exchange and other losses (gains) 6,536 (7,827)

(Favorable) adverse prior year loss development subject to LPT/ADC Agreement (7,840) 104,542

Income from discontinued operations, net of income tax — (75)

Interest expense paid under the LPT/ADC Agreement and the Commutation Agreement — 13,596

Loss from NGHC Quota Share run-off — 108

Non-GAAP operating (loss) earnings $ (2,313) $ 39,482

Diluted earnings (loss) per share attributable to common shareholders

$ 0.03 $ (0.70)

Add (subtract):

Net realized gains on investment (0.05) (0.15)

Total other-than-temporary impairment losses

Foreign exchange and other losses (gains) 0.07 (0.09)

(Favorable) adverse prior year loss development subject to LPT/ADC Agreement (0.09) 1.25

Interest expense paid under the LPT/ADC Agreement and the Commutation Agreement — 0.16

Non-GAAP diluted operating (loss) earnings per share attributable to common shareholders

$ (0.03) $ 0.47

For the Nine Months Ended September 30, 2020 2019

For the Three Months Ended March 31, 2021 2020

($ in thousands except per share data)

Net income (loss)

$ 32,235 $ (110,376)

Net income available to Maiden common shareholders $ 71,736 $ 20,861

Add (subtract):

Net realized gains on investment (8,101) (11,038)

(24,046) (25,685)

Total other-than-temporary impairment losses — 1,506

Foreign exchange and other losses (gains) 634 (14,013)

Loss from NGHC Quota Share run-off — 312

(Favorable) adverse prior year loss development subject to LPT/ADC Agreement (9,250) 104,542

Loss from discontinued operations, net of income tax — 22,048

Interest expense paid under the LPT/ADC Agreement and the Commutation Agreement — 13,596

Non-GAAP operating earnings (loss) $ 2,041 $ (9,411)

Diluted earnings (loss) per share attributable to common shareholders

$ 0.38 $ (1.33)

Foreign exchange and other gains (3,542) (8,197)

Interest in income of equity method investments (2,947) —

Favorable prior year loss development subject to LPT/ADC Agreement (9,845) —

Non-GAAP operating earnings $ 47,301 $ 3,132

Diluted earnings per share attributable to common shareholders $ 0.83 $ 0.25

Add (subtract):

Net realized gains on investment (0.09) (0.13)

(0.29) (0.31)

Total other-than-temporary impairment losses

Foreign exchange and other losses (gains) 0.01 (0.17)

Loss from NGHC Quota Share run-off

(Favorable) adverse prior year loss development subject to LPT/ADC Agreement (0.11) 1.26

Loss from discontinued operations, net of income tax

Interest expense paid under the LPT/ADC Agreement and the Commutation Agreement — 0.16

Non-GAAP diluted operating earnings (loss) per share attributable to common shareholders

Foreign exchange and other gains (0.04) (0.10)

Interest in income of equity method investments (0.03) —

Favorable prior year loss development subject to LPT/ADC Agreement (0.12) —

Non-GAAP diluted operating earnings per share available to common shareholders

$ 0.55 $ 0.04

Non-GAAP Operating ROACE

Non-GAAP Operating ROACE for the three and nine months ended September 30, 2020 and 2019 was computed as follows:

For the Three Months Ended September 30, For the Nine Months Ended September 30,

Non-GAAP Operating ROACE for the three months ended March 31, 2021 and 2020 was computed as follows:

For the Three Months Ended March 31,

($ in thousands) 2021 2020

Non-GAAP operating (loss) earnings $ (2,313) $ 39,482 $ 2,041 $ (9,411)

Non-GAAP operating earnings $ 47,301 $ 3,132

Opening adjusted common shareholders’ equity 208,447 155,668

2 unchanged sentences

Non-GAAP Operating ROACE

(5.6) % 105.0 % 1.8 % (9.6) %

Non-GAAP Underwriting Results and Combined Ratio

The following summarizes our non-GAAP underwriting results for the three and nine months ended September 30, 2020 and 2019:

For the Three Months Ended September 30, For the Nine Months Ended September 30,

The following summarizes our non-GAAP underwriting results for the three months ended March 31, 2021 and 2020:

For the Three Months Ended March 31,

($ in thousands) 2021 2020

7 unchanged sentences

General and administrative expenses (2,177) (2,257)

Non-GAAP underwriting (loss) income (1)

Non-GAAP underwriting loss (1)

$ (8,290) $ (3,693)

6 unchanged sentences

267.1 % 131.6 %

(1) Non-GAAP underwriting income (loss), non-GAAP net loss and LAE, non-GAAP net loss and LAE ratio, and non-GAAP combined ratio for the three and nine months ended September 30, 2020 and 2019 include the impact of prior year reserve development subject to the LPT/ADC Agreement in the respective periods.

Please see the "Key Financial Measures" section for definitions of Non-GAAP underwriting income (loss), net loss and LAE, non-GAAP net loss and LAE ratio, and non-GAAP combined ratio.

(1) Non-GAAP underwriting loss, non-GAAP net loss and LAE, non-GAAP net loss and LAE ratio, and non-GAAP combined ratio for the three months ended March 31, 2021 include the impact of prior year reserve development subject to the LPT/ADC Agreement.

Please see the "Key Financial Measures" section for definitions of Non-GAAP underwriting loss, net loss and LAE, non-GAAP net loss and LAE ratio, and non-GAAP combined ratio.

The non-GAAP underwriting results as well as the non-GAAP loss and LAE and ratios and non-GAAP combined ratios include the impact of prior year loss reserve development related to the AmTrust Quota Share which is fully recoverable from Cavello and subject to the LPT/ADC Agreement to show the ultimate economic benefit to the Company.

As shown in the table above, adjusted for the impact of favorable prior year reserve development subject to the LPT/ADC Agreement of $7.8 million and $9.3 million during the three and nine months ended September 30, 2020, respectively, the non-GAAP underwriting loss was $4.4 million and $9.6 million, respectively.

This compared to non-GAAP underwriting income of $24.3 million and a non-GAAP underwriting loss of $57.5 million for the same respective periods in 2019 when adjusted for the impact of adverse prior year reserve development subject to the LPT/ADC Agreement of $104.5 million during the three and nine months ended September 30, 2019.

The non-GAAP underwriting results in all respective periods were primarily the result of underwriting results in the AmTrust segment not covered by the LPT/ADC Agreement, specifically the run-off of the AmTrust Quota Share with losses occurring after December 31, 2018 (including the additional ceding commission paid under the Partial Termination Amendment) as well as claims related to the European Hospital Liability Quota Share.

Results in the Diversified segment during the three and nine months ended September 30, 2020 and 2019, respectively, were stable.

The non-GAAP combined ratio during the three and nine months ended September 30, 2020 was 141.3% and 136.5%, respectively, compared to 81.7% and 120.8% during the same respective periods in 2019 as shown in the table below:

For the Three Months Ended September 30, For the Nine Months Ended September 30,

2020 2019 2020 2019

As shown in the table above, adjusted for the impact of favorable prior year reserve development subject to the LPT/ADC Agreement of $9.8 million during the three months ended March 31, 2021, the non-GAAP underwriting loss was $8.3 million.

This compared to a non-GAAP underwriting loss of $3.7 million for the same period in 2020.

The non-GAAP underwriting results above were due to underwriting results in the AmTrust Reinsurance segment not covered by the LPT/ADC Agreement, specifically the run-off of the AmTrust Quota Share with losses occurring after December 31, 2018 (including the additional ceding commission paid under the Partial Termination Amendment) as well as claims related to the European Hospital Liability Quota Share.

Results in the Diversified Reinsurance segment during the three months ended March 31, 2021 and 2020, respectively, were stable.

The non-GAAP combined ratio during the three months ended March 31, 2021 was 267.1%, compared to 131.6% during the same period in 2020 as shown in the table below:

For the Three Months Ended March 31,

Combined ratio

185.3 % 131.6 %

change in unamortized deferred gain on retroactive reinsurance

(31.9) % 109.5 % (11.9) % 25.2 %

Favorable prior year loss development subject to LPT/ADC Agreement (81.8) % — %

Non-GAAP combined ratio 267.1 % 131.6 %

Non-GAAP Net Loss and LAE

As noted previously, adjusted for the impact of favorable prior year loss development on AmTrust reserves subject to the LPT/ADC Agreement, non-GAAP net loss and LAE for the three and nine months ended September 30, 2020 increased by $7.8 million and $9.3 million for the respective periods as these amounts are ultimately recoverable from Cavello.

In comparison, adjusted for the impact of adverse prior year loss development on AmTrust reserves subject to the LPT/ADC Agreement of $104.5 million during the three and nine months ended September 30, 2019, non-GAAP net loss and LAE decreased by $104.5 million for the same respective periods as these amounts are ultimately recoverable from Cavello.

These adjustments have been reflected in the calculation of non-GAAP Loss and LAE as shown in the table below:

For the Three Months Ended September 30, For the Nine Months Ended September 30,

Adjusted for the impact of favorable prior year loss development on AmTrust reserves subject to the LPT/ADC Agreement, non-GAAP net loss and LAE for the three months ended March 31, 2021 increased by $9.8 million as this amount is ultimately recoverable from Cavello.

This adjustment is reflected in the calculation of non-GAAP Loss and LAE as shown below:

For the Three Months Ended March 31,

($ in thousands) 2021 2020

1 unchanged sentence

$ 2,359 $ 21,086

impact of PPD subject to LPT/ADC Agreement (7,840) 104,542 (9,250) 104,542

Favorable prior year loss development subject to LPT/ADC Agreement (9,845) —

Non-GAAP net loss and LAE

$ 12,204 $ 21,086

Adjusted for the impact of favorable prior year loss development on AmTrust reserves subject to the LPT/ADC Agreement of $7.8 million and $9.3 million during the three and nine months ended September 30, 2020, non-GAAP net loss and LAE was $16.9 million and $50.4 million, respectively, as shown in the table above.

Adjusted for the impact of adverse prior year loss development on AmTrust reserves subject to the LPT/ADC Agreement of $104.5 million during the three and nine months ended September 30, 2019, non-GAAP net loss and LAE was $36.3 million and $310.6 million, respectively.

The non-GAAP net loss and LAE ratios were 68.8% and 64.8%, respectively, for the three and nine months ended September 30, 2020 compared to non-GAAP net loss ratios of 38.1% and 75.0% for the same respective periods in 2019.

Adjusted for the impact of favorable prior year loss development on AmTrust reserves subject to the LPT/ADC Agreement of $9.8 million during the three months ended March 31, 2021, non-GAAP net loss and LAE was $12.2 million as shown in the

The non-GAAP net loss and LAE ratio was 101.4% for the three months ended March 31, 2021 compared to 66.7% for the same period in 2020.

Adjusted Shareholders' Equity, Adjusted Total Capital Resources, Adjusted Book Value per Common Share, and Ratio of Debt to Total Adjusted Capital Resources

The Adjusted Shareholders' Equity, Adjusted Total Capital Resources and Adjusted Book Value per Common Share at September 30, 2020 and December 31, 2019 reflect the addition of the unamortized deferred gain on retroactive reinsurance to the GAAP shareholders' equity as depicted in the computations below.

The estimated deferred gain of $80.0 million at September 30, 2020 and $113.0 million at December 31, 2019 arises from the LPT/ADC Agreement with Cavello relating to losses subject to that agreement which are fully recoverable from Cavello.

The change in the unamortized deferred gain on retroactive reinsurance for the nine months ended September 30, 2020 is attributable to the following:

(1) $9.3 million in loss and loss adjustment expenses recognized as favorable loss development in the Company's GAAP income statement that are subject to the LPT/ADC Agreement;

and (2) $23.7 million related to a reduction in estimated ultimate losses for certain workers' compensation reserves previously commuted by the Company to AmTrust which are subject to specific terms and conditions pursuant to the LPT/ADC Agreement.

The Adjusted Shareholders' Equity, Adjusted Total Capital Resources and Adjusted Book Value per Common Share at March 31, 2021 and December 31, 2020 reflect the addition of the unamortized deferred gain on retroactive reinsurance to the GAAP shareholders' equity as depicted in the computations below.

The estimated deferred gain of $65.1 million at March 31, 2021 and $74.9 million at December 31, 2020 arises from the LPT/ADC Agreement with Cavello relating to losses subject to that agreement which are fully recoverable from Cavello.

The decrease in the unamortized deferred gain on retroactive reinsurance for the three months ended March 31, 2021 is attributable to $9.8 million in loss and loss adjustment expenses recognized as favorable loss development in the Company's GAAP income statement that are subject to the LPT/ADC Agreement.

We believe the inclusion of the unamortized deferred gain in these metrics better reflects the ultimate economic benefit of the LPT/ADC Agreement, which will improve the Company's shareholders' equity over the settlement period under the terms of the agreement.

Reconciliation of shareholders' equity to Adjusted shareholders' equity and Adjusted Total Capital Resources

The following table computes adjusted shareholders' equity and adjusted total capital resources by recognizing the unamortized deferred gain on retroactive reinsurance at September 30, 2020 and December 31, 2019:

($ in thousands) September 30, 2020 December 31, 2019 Change Change %

The following table computes adjusted shareholders' equity and adjusted total capital resources by recognizing the unamortized deferred gain on retroactive reinsurance at March 31, 2021 and December 31, 2020:

($ in thousands) March 31, 2021 December 31, 2020 Change Change %

Preference shares

12 unchanged sentences

Reconciliation of Book Value per Common Share to Adjusted Book Value per Common Share

The adjusted book value per common share as reconciled for the recognition of the unamortized deferred gain on retroactive reinsurance at September 30, 2020 and December 31, 2019 was computed as follows:

September 30, 2020 December 31, 2019

The adjusted book value per common share as reconciled for the recognition of the unamortized deferred gain on retroactive reinsurance at March 31, 2021 and December 31, 2020 was computed as follows:

March 31, 2021 December 31, 2020

Book value per common share

6 unchanged sentences

This measure is calculated using the total principal amount of debt divided by the sum of adjusted total capital resources as computed in the table above.

The ratio of Debt to Adjusted Total Capital Resources at September 30, 2020 and December 31, 2019 was computed as follows:

($ in thousands) September 30, 2020 December 31, 2019

The ratio of Debt to Adjusted Total Capital Resources at March 31, 2021 and December 31, 2020 was computed as follows:

($ in thousands) March 31, 2021 December 31, 2020

Senior notes - principal amount

15 unchanged sentences

To the extent that these exposures are not fully hedged or the hedges are ineffective, our results of operations or equity may be adversely affected.

At September 30, 2020, no such hedges or hedging strategies were in force or had been entered into.

At March 31, 2021, no such hedges or hedging strategies were in force or had been entered into.

We measure monetary assets and liabilities denominated in foreign currencies at period end exchange rates, with the resulting foreign exchange gains and losses recognized in the unaudited Condensed Consolidated Statements of Income.

1 unchanged sentence

The effect of the translation adjustments for foreign operations is included in AOCI.

Net foreign exchange losses of $6.5 million and $0.2 million were generated during the three and nine months ended September 30, 2020, respectively, compared to foreign exchange gains of $7.8 million and $9.7 million for the three and nine months ended September 30, 2019, respectively.

Net foreign exchange gains of $3.4 million were generated during the three months ended March 31, 2021, compared to foreign exchange gains of $8.4 million for the three months ended March 31, 2020.

Effects of Inflation

4 unchanged sentences

Off-Balance Sheet Arrangements

At September 30, 2020, we did not have any off-balance sheet arrangements as defined by Item 303(a) (4) of Regulation S-K.

At March 31, 2021, we did not have any off-balance sheet arrangements as defined by Item 303(a) (4) of Regulation S-K.

Recent Accounting Pronouncements

2 unchanged sentences

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 2. Management’s Discussion and Analysis